Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-27a-3p A1CF -0.61 0.09801 1.57 0.13497 MirTarget -0.66 0.00179 NA
2 hsa-miR-15a-5p A4GNT -0.74 0.01074 1.25 0.38275 MirTarget -1.28 0.00053 NA
3 hsa-miR-16-5p A4GNT -1.02 0.00033 1.25 0.38275 MirTarget -1.21 0.00119 NA
4 hsa-miR-484 AARS -1.18 5.0E-5 0.28 0.15374 miRNAWalker2 validate -0.1 0.04135 NA
5 hsa-miR-27a-3p ABAT -0.61 0.09801 0.38 0.56796 MirTarget -0.73 0 NA
6 hsa-miR-27a-5p ABAT 0.05 0.93885 0.38 0.56796 miRNATAP -0.17 0.0312 NA
7 hsa-miR-106b-5p ABCA1 -0.81 0.00943 -0.53 0.25827 MirTarget; miRNATAP -0.4 0.0003 NA
8 hsa-miR-130b-3p ABCA1 -0.37 0.37726 -0.53 0.25827 miRNATAP -0.17 0.03751 NA
9 hsa-miR-183-5p ABCA1 0.49 0.42168 -0.53 0.25827 MirTarget; miRNATAP -0.18 0.00189 26935154 MiR 183 functions as an oncogene by targeting ABCA1 in colon cancer; We found that miR-183 targets the 3'UTR of ABCA1 mRNA; Subsequent experiments confirmed that miR-183 degraded ABCA1 mRNA in the colon cancer cells; Thus we conclude that miR-183 promotes proliferation and inhibits apoptosis by degrading ABCA1 in colon cancer
10 hsa-miR-200a-3p ABCA1 1.69 0.00872 -0.53 0.25827 mirMAP -0.19 0.00033 NA
11 hsa-miR-16-2-3p ABCA10 -1.03 0.00735 -0.39 0.50843 mirMAP -0.26 0.01953 NA
12 hsa-miR-361-3p ABCA12 -0.26 0.36923 5.05 3.0E-5 MirTarget -1.21 0.00015 NA
13 hsa-miR-199b-5p ABCA17P 0.44 0.43893 0.04 0.95315 miRanda -0.33 6.0E-5 NA
14 hsa-miR-320a ABCA4 -0.53 0.10886 0.62 0.41421 miRanda -0.36 0.03881 NA
15 hsa-miR-183-5p ABCA8 0.49 0.42168 -0.99 0.28561 MirTarget -0.6 0 NA
16 hsa-miR-107 ABCB5 0.04 0.89912 -1.1 0.20934 MirTarget; miRanda -0.62 0.00774 NA
17 hsa-miR-15a-5p ABCB5 -0.74 0.01074 -1.1 0.20934 MirTarget -0.52 0.02298 NA
18 hsa-miR-16-5p ABCB5 -1.02 0.00033 -1.1 0.20934 MirTarget -0.65 0.00456 NA
19 hsa-miR-125b-5p ABCB9 0.4 0.2546 0.46 0.14647 mirMAP -0.22 0.00097 NA
20 hsa-miR-150-5p ABCB9 -1.91 0.02035 0.46 0.14647 MirTarget -0.12 1.0E-5 NA
21 hsa-miR-204-5p ABCC1 -1.13 0.19074 -0.07 0.78063 mirMAP -0.1 0 NA
22 hsa-miR-107 ABCC3 0.04 0.89912 0.56 0.4862 miRanda; miRNATAP -0.8 0.00018 NA
23 hsa-miR-16-5p ABCC4 -1.02 0.00033 -0.33 0.49338 miRNAWalker2 validate -0.26 0.04038 NA
24 hsa-miR-16-2-3p ABCC9 -1.03 0.00735 0.12 0.86565 mirMAP -0.86 0 NA
25 hsa-miR-106b-5p ABCD2 -0.81 0.00943 -1.98 0.01409 MirTarget -0.55 0.00453 NA
26 hsa-miR-16-2-3p ABCD2 -1.03 0.00735 -1.98 0.01409 mirMAP -0.49 0.00157 NA
27 hsa-miR-320a ABHD12 -0.53 0.10886 0.22 0.40184 miRanda -0.12 0.04516 NA
28 hsa-miR-16-2-3p ABHD13 -1.03 0.00735 -0.1 0.57584 mirMAP -0.14 6.0E-5 NA
29 hsa-miR-125a-5p ABHD2 -0.31 0.3708 0.63 0.15716 miRanda; mirMAP -0.27 0.00546 NA
30 hsa-miR-16-5p ABHD2 -1.02 0.00033 0.63 0.15716 miRNAWalker2 validate -0.48 3.0E-5 NA
31 hsa-miR-361-5p ABHD2 -0.3 0.18864 0.63 0.15716 PITA; mirMAP -0.41 0.00658 NA
32 hsa-miR-484 ABHD2 -1.18 5.0E-5 0.63 0.15716 miRNAWalker2 validate -0.37 0.00078 NA
33 hsa-miR-125a-5p ABHD3 -0.31 0.3708 0.21 0.58467 PITA; miRanda -0.18 0.02803 NA
34 hsa-miR-199b-5p ABHD6 0.44 0.43893 -0.35 0.27768 miRanda -0.22 0 NA
35 hsa-miR-27a-3p ABHD6 -0.61 0.09801 -0.35 0.27768 miRNATAP -0.26 5.0E-5 NA
36 hsa-miR-130b-3p ABI2 -0.37 0.37726 0.12 0.58647 mirMAP -0.12 0.00098 NA
37 hsa-miR-27a-3p ABI2 -0.61 0.09801 0.12 0.58647 mirMAP -0.12 0.00527 NA
38 hsa-miR-107 ABI3BP 0.04 0.89912 -0.32 0.6724 miRanda -0.56 0.00586 NA
39 hsa-miR-32-5p ABI3BP -1.17 0.00457 -0.32 0.6724 miRNATAP -0.56 3.0E-5 NA
40 hsa-miR-141-3p ABL1 1.13 0.09667 -0.28 0.25357 MirTarget -0.12 0 NA
41 hsa-miR-29a-3p ABL1 -0.39 0.22665 -0.28 0.25357 miRNAWalker2 validate; miRNATAP -0.21 0.00019 NA
42 hsa-miR-106b-5p ABL2 -0.81 0.00943 -0.13 0.63539 MirTarget -0.21 0.00182 NA
43 hsa-miR-141-3p ABL2 1.13 0.09667 -0.13 0.63539 MirTarget; TargetScan; miRNATAP -0.16 0 NA
44 hsa-miR-200a-3p ABL2 1.69 0.00872 -0.13 0.63539 MirTarget; miRNATAP -0.19 0 NA
45 hsa-miR-130b-5p ABLIM3 -0.5 0.28032 0.54 0.28206 mirMAP -0.28 0.00039 NA
46 hsa-miR-125b-5p ABTB1 0.4 0.2546 -0.09 0.79256 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.2 0.00439 NA
47 hsa-miR-144-3p ABTB2 -2.08 0.0115 0.09 0.87066 miRNATAP -0.11 0.01991 NA
48 hsa-miR-15a-5p ABTB2 -0.74 0.01074 0.09 0.87066 MirTarget -0.55 9.0E-5 NA
49 hsa-miR-16-5p ABTB2 -1.02 0.00033 0.09 0.87066 MirTarget -0.33 0.02286 NA
50 hsa-miR-16-2-3p ACADSB -1.03 0.00735 -0.21 0.50861 mirMAP -0.2 0.00129 NA
51 hsa-miR-107 ACADVL 0.04 0.89912 -0.22 0.43766 miRanda -0.19 0.01227 NA
52 hsa-miR-16-2-3p ACAP2 -1.03 0.00735 -0.2 0.41681 mirMAP -0.11 0.02037 NA
53 hsa-miR-125b-5p ACAP3 0.4 0.2546 -0.33 0.38761 miRNATAP -0.28 0.00052 NA
54 hsa-miR-320a ACAT1 -0.53 0.10886 -0.37 0.29673 miRanda -0.28 0.00032 NA
55 hsa-miR-16-2-3p ACBD5 -1.03 0.00735 0.2 0.4824 mirMAP -0.11 0.04244 NA
56 hsa-miR-107 ACCS 0.04 0.89912 -0.64 0.1402 miRanda -0.29 0.01303 NA
57 hsa-miR-199b-5p ACD 0.44 0.43893 -0.09 0.71068 miRanda -0.12 0.00016 NA
58 hsa-miR-361-5p ACER3 -0.3 0.18864 -0.19 0.51248 mirMAP -0.25 0.01 NA
59 hsa-miR-199b-5p ACLY 0.44 0.43893 0.2 0.41669 miRanda -0.12 0.00018 NA
60 hsa-miR-195-5p ACOT11 -0.69 0.07175 1.53 0.00052 mirMAP -0.23 0.00838 NA
61 hsa-miR-320a ACOT13 -0.53 0.10886 0.04 0.85073 miRanda -0.16 0.00076 NA
62 hsa-miR-125a-5p ACPP -0.31 0.3708 0.84 0.23008 MirTarget; miRanda -0.61 6.0E-5 NA
63 hsa-miR-15a-5p ACSL4 -0.74 0.01074 -0.57 0.06388 MirTarget; miRNATAP -0.2 0.01323 NA
64 hsa-miR-16-2-3p ACSL4 -1.03 0.00735 -0.57 0.06388 mirMAP -0.13 0.02972 NA
65 hsa-miR-375 ACSL5 2.46 0.01711 1.01 0.16492 miRNATAP -0.24 0 NA
66 hsa-miR-106b-5p ACSL6 -0.81 0.00943 -0.75 0.40323 mirMAP -0.45 0.03411 NA
67 hsa-miR-16-2-3p ACSL6 -1.03 0.00735 -0.75 0.40323 mirMAP -0.47 0.00676 NA
68 hsa-miR-125a-5p ACTBL2 -0.31 0.3708 1.45 0.14365 miRanda -0.65 0.00258 NA
69 hsa-miR-652-3p ACTG1 0.16 0.66997 -0.17 0.45053 miRNAWalker2 validate -0.2 1.0E-5 NA
70 hsa-miR-107 ACTG2 0.04 0.89912 0.67 0.55281 miRanda -1.08 0.00029 NA
71 hsa-miR-125a-5p ACTG2 -0.31 0.3708 0.67 0.55281 miRanda -0.66 0.00735 NA
72 hsa-miR-125a-5p ACTL6A -0.31 0.3708 0.27 0.19205 miRanda -0.18 2.0E-5 NA
73 hsa-miR-16-5p ACTN1 -1.02 0.00033 -0.03 0.91562 miRNAWalker2 validate -0.35 1.0E-5 NA
74 hsa-miR-125a-5p ACTN4 -0.31 0.3708 0.21 0.5222 mirMAP -0.22 0.0019 NA
75 hsa-miR-16-5p ACTN4 -1.02 0.00033 0.21 0.5222 miRNAWalker2 validate -0.22 0.00942 NA
76 hsa-miR-361-5p ACTN4 -0.3 0.18864 0.21 0.5222 miRanda -0.38 0.00047 NA
77 hsa-miR-652-3p ACTN4 0.16 0.66997 0.21 0.5222 miRNAWalker2 validate -0.23 0.00037 NA
78 hsa-miR-15a-5p ACTR2 -0.74 0.01074 -0.38 0.12012 MirTarget; miRNATAP -0.2 0.00123 NA
79 hsa-miR-320a ACTR3C -0.53 0.10886 0.02 0.95098 mirMAP -0.38 3.0E-5 NA
80 hsa-miR-130b-3p ACVR1 -0.37 0.37726 0.3 0.22609 miRNAWalker2 validate; MirTarget; miRNATAP -0.15 0.0005 NA
81 hsa-miR-16-2-3p ACVR1 -1.03 0.00735 0.3 0.22609 mirMAP -0.2 3.0E-5 NA
82 hsa-miR-10b-3p ACVR1B -0.53 0.21809 0.33 0.28594 mirMAP -0.18 0.00058 NA
83 hsa-miR-15a-5p ACVR1B -0.74 0.01074 0.33 0.28594 miRNAWalker2 validate -0.19 0.02059 NA
84 hsa-miR-130b-3p ACVR2A -0.37 0.37726 0.04 0.85285 miRNATAP -0.13 0.0008 NA
85 hsa-miR-15a-5p ACVR2A -0.74 0.01074 0.04 0.85285 MirTarget; miRNATAP -0.13 0.02472 NA
86 hsa-miR-16-5p ACVR2A -1.02 0.00033 0.04 0.85285 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.19 0.001 NA
87 hsa-miR-27a-3p ACVR2A -0.61 0.09801 0.04 0.85285 miRNATAP -0.11 0.00971 NA
88 hsa-miR-195-5p ACVR2B -0.69 0.07175 -0.22 0.43151 miRNATAP -0.19 0.00045 NA
89 hsa-miR-199b-5p ACVR2B 0.44 0.43893 -0.22 0.43151 PITA -0.24 0 NA
90 hsa-miR-320a ACVR2B -0.53 0.10886 -0.22 0.43151 miRNATAP -0.15 0.01851 NA
91 hsa-miR-361-5p ACY1 -0.3 0.18864 1 0.03263 miRanda -0.66 2.0E-5 NA
92 hsa-miR-199b-5p ACYP2 0.44 0.43893 -0.1 0.69502 miRanda -0.21 0 NA
93 hsa-miR-32-5p ADAM10 -1.17 0.00457 0.09 0.81886 MirTarget -0.33 0 NA
94 hsa-miR-130b-3p ADAM12 -0.37 0.37726 -1.12 0.25198 miRNATAP -0.35 0.04502 NA
95 hsa-miR-130b-5p ADAM12 -0.5 0.28032 -1.12 0.25198 mirMAP -0.35 0.02612 NA
96 hsa-miR-204-5p ADAM12 -1.13 0.19074 -1.12 0.25198 mirMAP -0.25 0.00217 NA
97 hsa-miR-29a-3p ADAM12 -0.39 0.22665 -1.12 0.25198 miRNATAP -0.55 0.01546 25886595 ADAM12 L is a direct target of the miR 29 and miR 200 families in breast cancer
98 hsa-miR-361-5p ADAM12 -0.3 0.18864 -1.12 0.25198 miRanda -1.14 0.00053 NA
99 hsa-miR-32-5p ADAM19 -1.17 0.00457 -0.94 0.15618 MirTarget; miRNATAP -0.36 0.00203 NA
100 hsa-miR-361-5p ADAM19 -0.3 0.18864 -0.94 0.15618 miRanda -0.46 0.04316 NA
101 hsa-miR-106b-5p ADAM22 -0.81 0.00943 -0.88 0.25527 MirTarget; mirMAP -0.71 9.0E-5 NA
102 hsa-miR-130b-3p ADAM22 -0.37 0.37726 -0.88 0.25527 mirMAP -0.53 0.0001 NA
103 hsa-miR-141-3p ADAM22 1.13 0.09667 -0.88 0.25527 MirTarget -0.33 7.0E-5 NA
104 hsa-miR-200a-3p ADAM22 1.69 0.00872 -0.88 0.25527 MirTarget -0.24 0.007 NA
105 hsa-miR-29a-3p ADAM22 -0.39 0.22665 -0.88 0.25527 miRNATAP -0.46 0.01138 NA
106 hsa-miR-32-5p ADAM22 -1.17 0.00457 -0.88 0.25527 mirMAP -0.64 0 NA
107 hsa-miR-130b-5p ADAM23 -0.5 0.28032 0.43 0.58572 mirMAP -0.25 0.0497 NA
108 hsa-miR-32-5p ADAM23 -1.17 0.00457 0.43 0.58572 miRNATAP -0.58 2.0E-5 NA
109 hsa-miR-361-5p ADAM28 -0.3 0.18864 -0.09 0.91558 mirMAP -1.07 7.0E-5 NA
110 hsa-miR-125a-5p ADAM9 -0.31 0.3708 0.41 0.38674 PITA; miRanda -0.25 0.01649 NA
111 hsa-miR-107 ADAMTS1 0.04 0.89912 -0.26 0.68323 miRanda -0.35 0.03788 NA
112 hsa-miR-125b-5p ADAMTS13 0.4 0.2546 0.09 0.85937 mirMAP -0.28 0.0081 NA
113 hsa-miR-107 ADAMTS14 0.04 0.89912 -0.08 0.91758 miRanda -0.75 0.00014 NA
114 hsa-miR-125a-5p ADAMTS14 -0.31 0.3708 -0.08 0.91758 miRanda; mirMAP -0.68 2.0E-5 NA
115 hsa-miR-361-3p ADAMTS14 -0.26 0.36923 -0.08 0.91758 mirMAP -0.53 0.00684 NA
116 hsa-miR-432-5p ADAMTS14 -0.19 0.74352 -0.08 0.91758 mirMAP -0.35 0.00019 NA
117 hsa-miR-130b-3p ADAMTS18 -0.37 0.37726 1.13 0.16158 miRNATAP -0.44 0.00193 NA
118 hsa-miR-29a-3p ADAMTS2 -0.39 0.22665 0 0.99864 MirTarget; miRNATAP -0.57 4.0E-5 NA
119 hsa-miR-107 ADAMTS3 0.04 0.89912 -0.85 0.21039 miRanda -0.41 0.02486 NA
120 hsa-miR-15a-5p ADAMTS3 -0.74 0.01074 -0.85 0.21039 miRNATAP -0.47 0.00735 NA
121 hsa-miR-16-2-3p ADAMTS3 -1.03 0.00735 -0.85 0.21039 mirMAP -0.43 0.001 NA
122 hsa-miR-16-5p ADAMTS3 -1.02 0.00033 -0.85 0.21039 miRNATAP -0.41 0.02157 NA
123 hsa-miR-106b-5p ADAMTS5 -0.81 0.00943 -0.73 0.15695 miRNATAP -0.33 0.0076 NA
124 hsa-miR-15a-5p ADAMTS5 -0.74 0.01074 -0.73 0.15695 miRNATAP -0.28 0.0362 NA
125 hsa-miR-29a-3p ADAMTS7 -0.39 0.22665 -0.47 0.38166 MirTarget; miRNATAP -0.41 0.00109 NA
126 hsa-miR-107 ADAMTS9 0.04 0.89912 -0.6 0.25854 miRanda -0.5 0.00032 NA
127 hsa-miR-125a-5p ADAMTS9 -0.31 0.3708 -0.6 0.25854 miRanda -0.26 0.02448 NA
128 hsa-miR-16-2-3p ADAMTS9 -1.03 0.00735 -0.6 0.25854 mirMAP -0.2 0.04376 NA
129 hsa-miR-107 ADAMTSL1 0.04 0.89912 -0.36 0.58349 miRanda -0.4 0.02363 NA
130 hsa-miR-130b-5p ADAMTSL1 -0.5 0.28032 -0.36 0.58349 mirMAP -0.26 0.012 NA
131 hsa-miR-27a-3p ADAMTSL1 -0.61 0.09801 -0.36 0.58349 miRNATAP -0.26 0.04725 NA
132 hsa-miR-32-5p ADAMTSL1 -1.17 0.00457 -0.36 0.58349 miRNATAP -0.6 0 NA
133 hsa-miR-320a ADAMTSL1 -0.53 0.10886 -0.36 0.58349 miRanda; mirMAP -0.31 0.04079 NA
134 hsa-miR-16-5p ADAMTSL3 -1.02 0.00033 -0.14 0.85623 MirTarget -0.48 0.01806 NA
135 hsa-miR-27a-3p ADAMTSL3 -0.61 0.09801 -0.14 0.85623 miRNATAP -0.71 0 NA
136 hsa-miR-32-5p ADAMTSL3 -1.17 0.00457 -0.14 0.85623 MirTarget; miRNATAP -0.43 0.00196 NA
137 hsa-miR-125a-5p ADAP1 -0.31 0.3708 1.46 0.03319 mirMAP -0.78 0 NA
138 hsa-miR-125b-5p ADAP1 0.4 0.2546 1.46 0.03319 mirMAP -0.3 0.04383 NA
139 hsa-miR-130b-3p ADAR -0.37 0.37726 0.04 0.82685 miRNAWalker2 validate -0.11 0.00023 NA
140 hsa-miR-106b-5p ADARB1 -0.81 0.00943 -0.6 0.08985 MirTarget -0.3 0.00028 NA
141 hsa-miR-130b-3p ADARB1 -0.37 0.37726 -0.6 0.08985 miRNAWalker2 validate -0.16 0.00922 NA
142 hsa-miR-141-3p ADARB1 1.13 0.09667 -0.6 0.08985 MirTarget -0.29 0 NA
143 hsa-miR-200a-3p ADARB1 1.69 0.00872 -0.6 0.08985 MirTarget -0.28 0 NA
144 hsa-miR-345-5p ADARB1 -1.2 0.00325 -0.6 0.08985 MirTarget -0.15 0.0178 NA
145 hsa-miR-106b-5p ADCY1 -0.81 0.00943 -0.03 0.96543 mirMAP -0.57 0.00233 NA
146 hsa-miR-27a-5p ADCY1 0.05 0.93885 -0.03 0.96543 MirTarget -0.29 0.00272 NA
147 hsa-miR-29a-3p ADCY1 -0.39 0.22665 -0.03 0.96543 mirMAP -0.44 0.01941 NA
148 hsa-miR-130b-3p ADCY2 -0.37 0.37726 0.27 0.71697 miRNATAP -0.52 5.0E-5 NA
149 hsa-miR-16-2-3p ADCY2 -1.03 0.00735 0.27 0.71697 mirMAP -0.73 0 NA
150 hsa-miR-16-5p ADCY2 -1.02 0.00033 0.27 0.71697 mirMAP -0.47 0.01452 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 NEUROGENESIS 551 1402 1.12e-47 5.21e-44
2 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 609 1672 1.886e-40 4.387e-37
3 REGULATION OF CELL DIFFERENTIATION 555 1492 1.055e-39 1.636e-36
4 CELL DEVELOPMENT 526 1426 2.053e-36 2.388e-33
5 CARDIOVASCULAR SYSTEM DEVELOPMENT 332 788 2.439e-35 1.891e-32
6 CIRCULATORY SYSTEM DEVELOPMENT 332 788 2.439e-35 1.891e-32
7 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 438 1142 1.068e-34 6.214e-32
8 TISSUE DEVELOPMENT 547 1518 1.05e-34 6.214e-32
9 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 398 1021 2.822e-33 1.459e-30
10 NEURON DIFFERENTIATION 353 874 4.451e-33 2.071e-30
11 REGULATION OF CELL DEVELOPMENT 338 836 8.746e-32 3.7e-29
12 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 373 957 3.575e-31 1.361e-28
13 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 234 513 3.803e-31 1.361e-28
14 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 462 1275 7.769e-30 2.582e-27
15 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 495 1395 1.727e-29 5.358e-27
16 ORGAN MORPHOGENESIS 333 841 2.506e-29 7.287e-27
17 REGULATION OF NEURON DIFFERENTIATION 243 554 3.928e-29 1.075e-26
18 VASCULATURE DEVELOPMENT 215 469 4.62e-29 1.16e-26
19 CELLULAR COMPONENT MORPHOGENESIS 350 900 4.737e-29 1.16e-26
20 REGULATION OF TRANSPORT 607 1804 4.999e-29 1.163e-26
21 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 304 750 7.379e-29 1.635e-26
22 INTRACELLULAR SIGNAL TRANSDUCTION 542 1572 9.689e-29 2.049e-26
23 NEURON PROJECTION DEVELOPMENT 239 545 1.192e-28 2.411e-26
24 REGULATION OF CELL PROJECTION ORGANIZATION 243 558 1.446e-28 2.803e-26
25 NEURON DEVELOPMENT 283 687 2.938e-28 5.468e-26
26 CELL PROJECTION ORGANIZATION 348 902 3.924e-28 7.022e-26
27 TUBE DEVELOPMENT 240 552 4.229e-28 7.288e-26
28 REGULATION OF CELLULAR COMPONENT MOVEMENT 308 771 6.138e-28 1.02e-25
29 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 561 1656 1.387e-27 2.152e-25
30 POSITIVE REGULATION OF MOLECULAR FUNCTION 598 1791 1.353e-27 2.152e-25
31 LOCOMOTION 408 1114 2.03e-27 3.047e-25
32 POSITIVE REGULATION OF CELL DIFFERENTIATION 321 823 6.088e-27 8.852e-25
33 REGULATION OF NEURON PROJECTION DEVELOPMENT 188 408 7.013e-26 9.889e-24
34 NEURON PROJECTION MORPHOGENESIS 185 402 2.099e-25 2.872e-23
35 REGULATION OF CELL MORPHOGENESIS 233 552 3.869e-25 5.144e-23
36 CENTRAL NERVOUS SYSTEM DEVELOPMENT 328 872 2.423e-24 3.132e-22
37 POSITIVE REGULATION OF CELL COMMUNICATION 514 1532 3.634e-24 4.569e-22
38 REGULATION OF CELL PROLIFERATION 504 1496 3.903e-24 4.779e-22
39 EPITHELIUM DEVELOPMENT 348 945 6.508e-24 7.765e-22
40 BLOOD VESSEL MORPHOGENESIS 168 364 2.382e-23 2.771e-21
41 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 169 368 3.443e-23 3.908e-21
42 PROTEIN LOCALIZATION 583 1805 6.161e-23 6.825e-21
43 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 158 337 6.661e-23 7.208e-21
44 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 577 1784 7.53e-23 7.963e-21
45 POSITIVE REGULATION OF GENE EXPRESSION 562 1733 1.536e-22 1.589e-20
46 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 268 689 2.033e-22 2.056e-20
47 TISSUE MORPHOGENESIS 220 533 2.645e-22 2.619e-20
48 HEAD DEVELOPMENT 271 709 2.184e-21 2.117e-19
49 UROGENITAL SYSTEM DEVELOPMENT 142 299 2.289e-21 2.174e-19
50 CELL PART MORPHOGENESIS 248 633 2.627e-21 2.444e-19
51 NEGATIVE REGULATION OF CELL COMMUNICATION 408 1192 5.782e-21 5.276e-19
52 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 572 1805 2.053e-20 1.837e-18
53 POSITIVE REGULATION OF CATALYTIC ACTIVITY 495 1518 2.22e-20 1.949e-18
54 BIOLOGICAL ADHESION 361 1032 2.328e-20 2.006e-18
55 NEURON PROJECTION GUIDANCE 107 205 2.731e-20 2.311e-18
56 REGULATION OF PROTEIN MODIFICATION PROCESS 545 1710 5.001e-20 4.155e-18
57 REGULATION OF CELL DEATH 481 1472 5.246e-20 4.283e-18
58 POSITIVE REGULATION OF CELL DEVELOPMENT 195 472 5.931e-20 4.758e-18
59 HEART DEVELOPMENT 193 466 6.647e-20 5.242e-18
60 TUBE MORPHOGENESIS 147 323 6.956e-20 5.394e-18
61 REGULATION OF PHOSPHORUS METABOLIC PROCESS 519 1618 1.054e-19 8.036e-18
62 POSITIVE REGULATION OF RESPONSE TO STIMULUS 601 1929 1.35e-19 1.013e-17
63 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 183 437 1.522e-19 1.124e-17
64 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 350 1004 1.733e-19 1.26e-17
65 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 579 1848 1.868e-19 1.337e-17
66 ANGIOGENESIS 136 293 2.031e-19 1.432e-17
67 RESPONSE TO ENDOGENOUS STIMULUS 472 1450 2.8e-19 1.944e-17
68 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 390 1152 3.872e-19 2.649e-17
69 POSITIVE REGULATION OF NEURON DIFFERENTIATION 139 306 8.721e-19 5.881e-17
70 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 348 1008 1.256e-18 8.347e-17
71 MORPHOGENESIS OF AN EPITHELIUM 169 400 1.327e-18 8.589e-17
72 EMBRYONIC MORPHOGENESIS 212 539 1.329e-18 8.589e-17
73 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 443 1360 3.556e-18 2.267e-16
74 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 136 303 7.3e-18 4.59e-16
75 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 111 229 7.935e-18 4.797e-16
76 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 605 1977 7.855e-18 4.797e-16
77 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 477 1492 7.938e-18 4.797e-16
78 SKELETAL SYSTEM DEVELOPMENT 184 455 9.537e-18 5.689e-16
79 EMBRYO DEVELOPMENT 312 894 1.54e-17 9.068e-16
80 ESTABLISHMENT OF LOCALIZATION IN CELL 524 1676 2.071e-17 1.205e-15
81 RESPONSE TO GROWTH FACTOR 189 475 2.52e-17 1.448e-15
82 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 111 232 2.673e-17 1.517e-15
83 PROTEIN PHOSPHORYLATION 325 944 2.98e-17 1.671e-15
84 REGULATION OF AXONOGENESIS 88 168 4.576e-17 2.535e-15
85 REGULATION OF GTPASE ACTIVITY 247 673 5.04e-17 2.759e-15
86 NEGATIVE REGULATION OF CELL PROLIFERATION 238 643 6.049e-17 3.273e-15
87 CELL MOTILITY 293 835 6.878e-17 3.637e-15
88 LOCALIZATION OF CELL 293 835 6.878e-17 3.637e-15
89 REGULATION OF CELLULAR LOCALIZATION 415 1277 7.143e-17 3.735e-15
90 POSITIVE REGULATION OF HYDROLASE ACTIVITY 312 905 1.082e-16 5.594e-15
91 REGULATION OF PROTEIN LOCALIZATION 324 950 1.534e-16 7.841e-15
92 GLAND DEVELOPMENT 162 395 1.922e-16 9.721e-15
93 NEGATIVE REGULATION OF CELL DEATH 301 872 3.207e-16 1.604e-14
94 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 373 1135 4.685e-16 2.319e-14
95 ESTABLISHMENT OF PROTEIN LOCALIZATION 450 1423 6.212e-16 3.043e-14
96 REGULATION OF DEVELOPMENTAL GROWTH 126 289 1.866e-15 9.042e-14
97 REGULATION OF EPITHELIAL CELL PROLIFERATION 124 285 3.763e-15 1.805e-13
98 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 189 498 6.526e-15 3.098e-13
99 FOREBRAIN DEVELOPMENT 146 357 7.859e-15 3.694e-13
100 NEGATIVE REGULATION OF CELL DIFFERENTIATION 221 609 9.502e-15 4.421e-13
101 REGULATION OF CELLULAR COMPONENT BIOGENESIS 266 767 9.874e-15 4.549e-13
102 POSITIVE REGULATION OF TRANSPORT 313 936 1.02e-14 4.653e-13
103 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 275 801 1.383e-14 6.249e-13
104 POSITIVE REGULATION OF LOCOMOTION 164 420 2.357e-14 1.054e-12
105 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 81 162 2.436e-14 1.079e-12
106 DIGESTIVE SYSTEM DEVELOPMENT 76 148 2.481e-14 1.089e-12
107 EXTRACELLULAR STRUCTURE ORGANIZATION 128 304 2.758e-14 1.199e-12
108 REGULATION OF HYDROLASE ACTIVITY 416 1327 3.974e-14 1.712e-12
109 TELENCEPHALON DEVELOPMENT 103 228 4.298e-14 1.835e-12
110 RESPONSE TO OXYGEN CONTAINING COMPOUND 430 1381 4.593e-14 1.943e-12
111 REGULATION OF GROWTH 225 633 6.786e-14 2.844e-12
112 CELLULAR MACROMOLECULE LOCALIZATION 389 1234 1.198e-13 4.975e-12
113 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 292 876 1.308e-13 5.386e-12
114 STEM CELL DIFFERENTIATION 89 190 1.755e-13 7.165e-12
115 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 335 1036 1.857e-13 7.449e-12
116 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 335 1036 1.857e-13 7.449e-12
117 MORPHOGENESIS OF A BRANCHING STRUCTURE 81 167 2.043e-13 8.125e-12
118 POSITIVE REGULATION OF CELL PROLIFERATION 274 814 2.17e-13 8.557e-12
119 CONNECTIVE TISSUE DEVELOPMENT 90 194 2.59e-13 1.013e-11
120 PHOSPHORYLATION 385 1228 3.839e-13 1.489e-11
121 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 319 983 4.418e-13 1.699e-11
122 APPENDAGE DEVELOPMENT 81 169 4.597e-13 1.739e-11
123 LIMB DEVELOPMENT 81 169 4.597e-13 1.739e-11
124 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 268 799 6.319e-13 2.371e-11
125 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 116 278 9.203e-13 3.426e-11
126 RESPONSE TO WOUNDING 201 563 9.415e-13 3.477e-11
127 TAXIS 172 464 1.165e-12 4.243e-11
128 MESENCHYMAL CELL DIFFERENTIATION 68 134 1.167e-12 4.243e-11
129 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 101 232 1.265e-12 4.563e-11
130 REGULATION OF OSSIFICATION 83 178 1.543e-12 5.522e-11
131 MESENCHYME DEVELOPMENT 87 190 1.587e-12 5.636e-11
132 SENSORY ORGAN DEVELOPMENT 180 493 1.622e-12 5.718e-11
133 HEART MORPHOGENESIS 94 212 2.092e-12 7.317e-11
134 CELL CELL ADHESION 212 608 3.057e-12 1.061e-10
135 HOMEOSTATIC PROCESS 409 1337 3.466e-12 1.195e-10
136 MUSCLE STRUCTURE DEVELOPMENT 161 432 3.739e-12 1.279e-10
137 MEMBRANE ORGANIZATION 292 899 4.078e-12 1.385e-10
138 EPITHELIAL CELL DIFFERENTIATION 179 495 4.85e-12 1.635e-10
139 CELL DEATH 319 1001 5.366e-12 1.796e-10
140 CELL PROLIFERATION 229 672 5.588e-12 1.857e-10
141 RESPONSE TO ABIOTIC STIMULUS 325 1024 5.834e-12 1.925e-10
142 POSITIVE REGULATION OF CELL DEATH 210 605 6.297e-12 2.064e-10
143 REGULATION OF VESICLE MEDIATED TRANSPORT 169 462 6.534e-12 2.126e-10
144 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 91 207 8.391e-12 2.711e-10
145 REGULATION OF ORGAN MORPHOGENESIS 102 242 1.048e-11 3.364e-10
146 KIDNEY EPITHELIUM DEVELOPMENT 63 125 1.145e-11 3.65e-10
147 DIGESTIVE TRACT MORPHOGENESIS 33 48 1.408e-11 4.456e-10
148 OSSIFICATION 104 251 2.261e-11 7.109e-10
149 VESICLE MEDIATED TRANSPORT 379 1239 2.339e-11 7.303e-10
150 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 53 99 2.522e-11 7.771e-10
151 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 53 99 2.522e-11 7.771e-10
152 REGULATION OF ION TRANSPORT 204 592 2.671e-11 8.176e-10
153 REGULATION OF CELL ADHESION 214 629 3.323e-11 1.011e-09
154 REGULATION OF CELL SIZE 78 172 4.003e-11 1.209e-09
155 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 64 131 4.478e-11 1.344e-09
156 REGULATION OF KINASE ACTIVITY 254 776 4.521e-11 1.349e-09
157 POSITIVE REGULATION OF AXONOGENESIS 41 69 5.682e-11 1.684e-09
158 DEVELOPMENTAL GROWTH 128 333 5.724e-11 1.686e-09
159 PEPTIDYL AMINO ACID MODIFICATION 271 841 6.389e-11 1.87e-09
160 REGULATION OF OSTEOBLAST DIFFERENTIATION 57 112 6.571e-11 1.911e-09
161 REGULATION OF EXTENT OF CELL GROWTH 53 101 6.866e-11 1.984e-09
162 MUSCLE TISSUE DEVELOPMENT 110 275 8e-11 2.298e-09
163 REGULATION OF HOMEOSTATIC PROCESS 161 447 8.156e-11 2.328e-09
164 SECRETION 201 588 8.333e-11 2.364e-09
165 CHEMICAL HOMEOSTASIS 279 874 1.01e-10 2.847e-09
166 SINGLE ORGANISM CELL ADHESION 164 459 1.107e-10 3.103e-09
167 GLIOGENESIS 78 175 1.127e-10 3.14e-09
168 EYE DEVELOPMENT 125 326 1.156e-10 3.202e-09
169 CELLULAR RESPONSE TO NITROGEN COMPOUND 177 505 1.21e-10 3.331e-09
170 REGULATION OF MEMBRANE POTENTIAL 130 343 1.222e-10 3.344e-09
171 ION TRANSPORT 381 1262 1.329e-10 3.617e-09
172 RESPONSE TO OXYGEN LEVELS 120 311 1.71e-10 4.626e-09
173 IMMUNE SYSTEM DEVELOPMENT 198 582 1.833e-10 4.93e-09
174 POSITIVE REGULATION OF OSSIFICATION 46 84 1.866e-10 4.991e-09
175 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 67 144 2.382e-10 6.334e-09
176 REGULATION OF MAPK CASCADE 219 660 2.61e-10 6.901e-09
177 REGULATION OF CELLULAR PROTEIN LOCALIZATION 189 552 2.636e-10 6.929e-09
178 NEGATIVE REGULATION OF CELL DEVELOPMENT 117 303 2.732e-10 7.142e-09
179 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 59 121 2.793e-10 7.261e-09
180 REGULATION OF TRANSFERASE ACTIVITY 296 946 3.03e-10 7.834e-09
181 RESPIRATORY SYSTEM DEVELOPMENT 84 197 3.406e-10 8.755e-09
182 GROWTH 148 410 3.938e-10 1.007e-08
183 RESPONSE TO NITROGEN COMPOUND 272 859 4.386e-10 1.115e-08
184 CEREBRAL CORTEX DEVELOPMENT 53 105 4.486e-10 1.134e-08
185 CELL SUBSTRATE ADHESION 73 164 4.735e-10 1.191e-08
186 GLAND MORPHOGENESIS 50 97 5.376e-10 1.345e-08
187 CARBOHYDRATE DERIVATIVE METABOLIC PROCESS 321 1047 6.644e-10 1.653e-08
188 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 239 740 7.009e-10 1.735e-08
189 CARDIAC CHAMBER DEVELOPMENT 66 144 7.125e-10 1.745e-08
190 CARTILAGE DEVELOPMENT 67 147 7.121e-10 1.745e-08
191 BEHAVIOR 177 516 8.304e-10 2.023e-08
192 RESPONSE TO ORGANIC CYCLIC COMPOUND 286 917 8.863e-10 2.148e-08
193 RESPONSE TO EXTERNAL STIMULUS 519 1821 9.311e-10 2.244e-08
194 REGULATION OF CATABOLIC PROCESS 236 731 9.357e-10 2.244e-08
195 GLIAL CELL DIFFERENTIATION 63 136 1.012e-09 2.414e-08
196 CELL JUNCTION ORGANIZATION 79 185 1.039e-09 2.466e-08
197 REGULATION OF TRANSMEMBRANE TRANSPORT 151 426 1.145e-09 2.705e-08
198 REGULATION OF ANATOMICAL STRUCTURE SIZE 164 472 1.205e-09 2.817e-08
199 REGULATION OF CELL SUBSTRATE ADHESION 75 173 1.2e-09 2.817e-08
200 REGULATION OF CELLULAR COMPONENT SIZE 125 337 1.334e-09 3.105e-08
201 CELLULAR RESPONSE TO EXTERNAL STIMULUS 103 264 1.622e-09 3.755e-08
202 REGULATION OF BODY FLUID LEVELS 173 506 1.705e-09 3.926e-08
203 PATTERN SPECIFICATION PROCESS 148 418 1.823e-09 4.178e-08
204 REGULATION OF METAL ION TRANSPORT 121 325 1.88e-09 4.288e-08
205 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 69 156 1.951e-09 4.428e-08
206 SECRETION BY CELL 167 486 2.154e-09 4.866e-08
207 ENDOMEMBRANE SYSTEM ORGANIZATION 161 465 2.272e-09 5.107e-08
208 REGULATION OF WNT SIGNALING PATHWAY 116 310 2.873e-09 6.427e-08
209 POSITIVE REGULATION OF MAPK CASCADE 162 470 2.921e-09 6.503e-08
210 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 221 684 2.992e-09 6.63e-08
211 POSITIVE REGULATION OF KINASE ACTIVITY 165 482 3.657e-09 8.065e-08
212 MESONEPHROS DEVELOPMENT 46 90 3.72e-09 8.166e-08
213 REGULATION OF SYNAPSE ORGANIZATION 54 113 3.925e-09 8.574e-08
214 REGULATION OF CELL GROWTH 139 391 4.191e-09 9.112e-08
215 CARDIAC MUSCLE TISSUE DEVELOPMENT 63 140 4.235e-09 9.165e-08
216 REGULATION OF ACTIN FILAMENT BASED PROCESS 116 312 4.424e-09 9.529e-08
217 RESPONSE TO HORMONE 276 893 4.709e-09 1.01e-07
218 CARDIAC SEPTUM DEVELOPMENT 44 85 4.853e-09 1.036e-07
219 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 50 102 4.983e-09 1.059e-07
220 REGULATION OF SECRETION 224 699 5.133e-09 1.086e-07
221 RESPONSE TO MECHANICAL STIMULUS 85 210 5.613e-09 1.182e-07
222 CELL JUNCTION ASSEMBLY 59 129 6.166e-09 1.292e-07
223 NEGATIVE REGULATION OF PHOSPHORYLATION 147 422 7.146e-09 1.491e-07
224 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 230 724 7.394e-09 1.536e-07
225 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 84 208 7.805e-09 1.614e-07
226 REGULATION OF APOPTOTIC SIGNALING PATHWAY 130 363 7.913e-09 1.629e-07
227 PEPTIDYL SERINE MODIFICATION 65 148 7.999e-09 1.64e-07
228 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 151 437 8.288e-09 1.691e-07
229 INTRACELLULAR PROTEIN TRANSPORT 245 781 8.39e-09 1.705e-07
230 COGNITION 97 251 8.491e-09 1.718e-07
231 NEPHRON DEVELOPMENT 54 115 8.556e-09 1.718e-07
232 GLYCOPROTEIN METABOLIC PROCESS 127 353 8.565e-09 1.718e-07
233 IMMUNE SYSTEM PROCESS 553 1984 8.951e-09 1.788e-07
234 WOUND HEALING 160 470 9.721e-09 1.933e-07
235 REGULATION OF CYTOPLASMIC TRANSPORT 163 481 1.014e-08 2.007e-07
236 EMBRYONIC ORGAN MORPHOGENESIS 105 279 1.118e-08 2.2e-07
237 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 78 190 1.121e-08 2.2e-07
238 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 179 541 1.436e-08 2.796e-07
239 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 179 541 1.436e-08 2.796e-07
240 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 66 153 1.472e-08 2.841e-07
241 PALLIUM DEVELOPMENT 66 153 1.472e-08 2.841e-07
242 REGULATION OF CARTILAGE DEVELOPMENT 35 63 1.664e-08 3.199e-07
243 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 61 138 1.698e-08 3.238e-07
244 ODONTOGENESIS 50 105 1.692e-08 3.238e-07
245 EMBRYONIC ORGAN DEVELOPMENT 141 406 1.79e-08 3.399e-07
246 MAMMARY GLAND DEVELOPMENT 54 117 1.809e-08 3.423e-07
247 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 199 616 1.861e-08 3.507e-07
248 PROTEIN AUTOPHOSPHORYLATION 78 192 1.938e-08 3.635e-07
249 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 36 66 1.999e-08 3.715e-07
250 POSITIVE REGULATION OF GROWTH 92 238 2.004e-08 3.715e-07
251 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 36 66 1.999e-08 3.715e-07
252 REGULATION OF SYSTEM PROCESS 169 507 2.033e-08 3.755e-07
253 SINGLE ORGANISM CELLULAR LOCALIZATION 274 898 2.046e-08 3.763e-07
254 SYNAPSE ORGANIZATION 63 145 2.229e-08 4.083e-07
255 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 99 262 2.293e-08 4.183e-07
256 RESPONSE TO ALCOHOL 128 362 2.447e-08 4.447e-07
257 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 157 465 2.488e-08 4.505e-07
258 INOSITOL LIPID MEDIATED SIGNALING 56 124 2.579e-08 4.652e-07
259 PLASMA MEMBRANE ORGANIZATION 81 203 2.709e-08 4.867e-07
260 OUTFLOW TRACT MORPHOGENESIS 32 56 2.724e-08 4.874e-07
261 METAL ION TRANSPORT 189 582 2.758e-08 4.879e-07
262 REGULATION OF RESPONSE TO STRESS 420 1468 2.738e-08 4.879e-07
263 REGULATION OF ORGANELLE ORGANIZATION 346 1178 2.754e-08 4.879e-07
264 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 158 470 3.115e-08 5.49e-07
265 MODULATION OF SYNAPTIC TRANSMISSION 110 301 3.219e-08 5.652e-07
266 HINDBRAIN DEVELOPMENT 60 137 3.356e-08 5.87e-07
267 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 170 514 3.405e-08 5.933e-07
268 CELL FATE COMMITMENT 88 227 3.452e-08 5.993e-07
269 MUSCLE CELL DIFFERENTIATION 91 237 3.469e-08 6.001e-07
270 METANEPHROS DEVELOPMENT 41 81 3.701e-08 6.362e-07
271 REGULATION OF INTRACELLULAR TRANSPORT 199 621 3.705e-08 6.362e-07
272 CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT 53 116 3.732e-08 6.384e-07
273 SKELETAL SYSTEM MORPHOGENESIS 80 201 3.75e-08 6.392e-07
274 VENTRICULAR SEPTUM DEVELOPMENT 31 54 3.868e-08 6.568e-07
275 ACTIN FILAMENT BASED PROCESS 152 450 4.012e-08 6.788e-07
276 WNT SIGNALING PATHWAY 124 351 4.266e-08 7.173e-07
277 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 69 166 4.27e-08 7.173e-07
278 REGULATION OF CELL MATRIX ADHESION 44 90 4.518e-08 7.561e-07
279 ION TRANSMEMBRANE TRANSPORT 252 822 4.899e-08 8.171e-07
280 SINGLE ORGANISM BEHAVIOR 133 384 5.399e-08 8.972e-07
281 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 180 554 5.655e-08 9.337e-07
282 RESPONSE TO LIPID 269 888 5.659e-08 9.337e-07
283 NEGATIVE REGULATION OF GENE EXPRESSION 424 1493 6.036e-08 9.897e-07
284 CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS 191 595 6.041e-08 9.897e-07
285 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 430 1517 6.143e-08 1.003e-06
286 REGULATION OF VASCULATURE DEVELOPMENT 89 233 6.462e-08 1.051e-06
287 ENSHEATHMENT OF NEURONS 44 91 6.831e-08 1.104e-06
288 AXON ENSHEATHMENT 44 91 6.831e-08 1.104e-06
289 CARDIAC VENTRICLE DEVELOPMENT 49 106 7.646e-08 1.231e-06
290 CELLULAR RESPONSE TO OXYGEN LEVELS 61 143 8.339e-08 1.338e-06
291 CELL ACTIVATION 183 568 8.565e-08 1.37e-06
292 REGULATION OF CELLULAR RESPONSE TO STRESS 216 691 8.776e-08 1.394e-06
293 CELLULAR HOMEOSTASIS 212 676 8.771e-08 1.394e-06
294 NEURAL CREST CELL DIFFERENTIATION 38 75 1.119e-07 1.771e-06
295 EPITHELIAL CELL DEVELOPMENT 74 186 1.219e-07 1.923e-06
296 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 64 154 1.309e-07 2.057e-06
297 REPRODUCTIVE SYSTEM DEVELOPMENT 138 408 1.526e-07 2.391e-06
298 PEPTIDYL THREONINE MODIFICATION 27 46 1.552e-07 2.406e-06
299 REGULATION OF CHONDROCYTE DIFFERENTIATION 27 46 1.552e-07 2.406e-06
300 CARDIOCYTE DIFFERENTIATION 45 96 1.546e-07 2.406e-06
301 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 75 191 1.882e-07 2.909e-06
302 REGULATION OF ION HOMEOSTASIS 78 201 1.924e-07 2.964e-06
303 KIDNEY MORPHOGENESIS 40 82 1.97e-07 3.025e-06
304 PALATE DEVELOPMENT 41 85 2.057e-07 3.148e-06
305 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 51 115 2.161e-07 3.296e-06
306 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 32 60 2.431e-07 3.697e-06
307 REGULATION OF CYTOSKELETON ORGANIZATION 163 502 2.484e-07 3.765e-06
308 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 88 236 2.677e-07 4.044e-06
309 AMINO ACID IMPORT 13 15 2.769e-07 4.17e-06
310 CATION TRANSPORT 241 796 2.943e-07 4.418e-06
311 TRANSMEMBRANE TRANSPORT 319 1098 3.075e-07 4.601e-06
312 CELLULAR RESPONSE TO STRESS 437 1565 3.127e-07 4.664e-06
313 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 44 95 3.24e-07 4.816e-06
314 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 136 406 3.498e-07 5.184e-06
315 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 72 184 3.838e-07 5.669e-06
316 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 123 360 3.879e-07 5.711e-06
317 ARTERY DEVELOPMENT 37 75 3.907e-07 5.735e-06
318 INTERSPECIES INTERACTION BETWEEN ORGANISMS 205 662 3.979e-07 5.803e-06
319 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 205 662 3.979e-07 5.803e-06
320 REGULATION OF DENDRITE DEVELOPMENT 52 120 4.036e-07 5.869e-06
321 ION HOMEOSTASIS 182 576 4.097e-07 5.938e-06
322 RENAL TUBULE DEVELOPMENT 38 78 4.117e-07 5.949e-06
323 REGULATION OF BINDING 101 283 4.28e-07 6.165e-06
324 MAMMARY GLAND EPITHELIUM DEVELOPMENT 29 53 4.319e-07 6.202e-06
325 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 49 111 4.393e-07 6.29e-06
326 DIVALENT INORGANIC CATION HOMEOSTASIS 118 343 4.44e-07 6.338e-06
327 NEPHRON EPITHELIUM DEVELOPMENT 43 93 4.658e-07 6.628e-06
328 NEGATIVE REGULATION OF LOCOMOTION 95 263 5.003e-07 7.098e-06
329 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 30 56 5.063e-07 7.139e-06
330 SENSORY ORGAN MORPHOGENESIS 88 239 5.061e-07 7.139e-06
331 GOLGI VESICLE TRANSPORT 111 319 5.095e-07 7.162e-06
332 RHYTHMIC PROCESS 105 298 5.192e-07 7.276e-06
333 CELLULAR RESPONSE TO HORMONE STIMULUS 175 552 5.359e-07 7.488e-06
334 BONE DEVELOPMENT 63 156 5.525e-07 7.697e-06
335 REGULATION OF SYNAPTIC PLASTICITY 58 140 5.635e-07 7.826e-06
336 COLLAGEN FIBRIL ORGANIZATION 23 38 6.024e-07 8.317e-06
337 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 23 38 6.024e-07 8.317e-06
338 REGULATION OF SYNAPSE ASSEMBLY 38 79 6.202e-07 8.538e-06
339 REGULATION OF MUSCLE TISSUE DEVELOPMENT 46 103 6.525e-07 8.956e-06
340 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 45 100 6.619e-07 9.058e-06
341 ACTION POTENTIAL 43 94 6.709e-07 9.154e-06
342 DIVALENT INORGANIC CATION TRANSPORT 96 268 6.754e-07 9.19e-06
343 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 82 220 6.861e-07 9.308e-06
344 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 52 122 7.518e-07 1.017e-05
345 NERVE DEVELOPMENT 34 68 7.682e-07 1.036e-05
346 CELL MATRIX ADHESION 51 119 7.826e-07 1.049e-05
347 L AMINO ACID IMPORT 11 12 7.823e-07 1.049e-05
348 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 75 197 7.861e-07 1.051e-05
349 CELLULAR CHEMICAL HOMEOSTASIS 179 570 7.96e-07 1.061e-05
350 POSITIVE REGULATION OF AXON EXTENSION 22 36 8.389e-07 1.115e-05
351 REGULATION OF STEM CELL DIFFERENTIATION 49 113 8.409e-07 1.115e-05
352 PROTEIN LOCALIZATION TO MEMBRANE 126 376 9.086e-07 1.201e-05
353 CARDIAC CHAMBER MORPHOGENESIS 46 104 9.14e-07 1.201e-05
354 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 46 104 9.14e-07 1.201e-05
355 CELLULAR RESPONSE TO MECHANICAL STIMULUS 38 80 9.237e-07 1.211e-05
356 MEMORY 44 98 9.473e-07 1.235e-05
357 REGULATION OF MAP KINASE ACTIVITY 110 319 9.454e-07 1.235e-05
358 RESPONSE TO STEROID HORMONE 159 497 9.573e-07 1.244e-05
359 CELLULAR RESPONSE TO ABIOTIC STIMULUS 94 263 9.826e-07 1.274e-05
360 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 19 29 1.025e-06 1.325e-05
361 CELLULAR RESPONSE TO LIPID 148 457 1.036e-06 1.335e-05
362 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 12 14 1.062e-06 1.365e-05
363 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 50 117 1.108e-06 1.42e-05
364 LEUKOCYTE DIFFERENTIATION 102 292 1.184e-06 1.513e-05
365 REGULATION OF PROTEIN CATABOLIC PROCESS 130 393 1.342e-06 1.71e-05
366 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 133 404 1.36e-06 1.729e-05
367 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 190 616 1.406e-06 1.783e-05
368 ACTIVATION OF PROTEIN KINASE ACTIVITY 98 279 1.435e-06 1.815e-05
369 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 55 134 1.549e-06 1.948e-05
370 INTERACTION WITH HOST 55 134 1.549e-06 1.948e-05
371 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 122 365 1.557e-06 1.953e-05
372 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 58 144 1.691e-06 2.115e-05
373 REGULATION OF FAT CELL DIFFERENTIATION 46 106 1.754e-06 2.188e-05
374 AMEBOIDAL TYPE CELL MIGRATION 61 154 1.79e-06 2.225e-05
375 REGULATION OF CELL CYCLE 276 949 1.794e-06 2.225e-05
376 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 45 103 1.809e-06 2.239e-05
377 CELL CELL SIGNALING 229 767 1.816e-06 2.242e-05
378 METENCEPHALON DEVELOPMENT 44 100 1.859e-06 2.289e-05
379 RESPONSE TO ESTROGEN 80 218 1.9e-06 2.327e-05
380 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 80 218 1.9e-06 2.327e-05
381 PROTEIN LOCALIZATION TO CELL PERIPHERY 60 151 1.919e-06 2.344e-05
382 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 37 79 1.962e-06 2.39e-05
383 EPITHELIAL TO MESENCHYMAL TRANSITION 29 56 1.967e-06 2.39e-05
384 INTEGRIN MEDIATED SIGNALING PATHWAY 38 82 1.983e-06 2.403e-05
385 CYTOSOLIC TRANSPORT 79 215 2.074e-06 2.507e-05
386 REGULATION OF TRANSPORTER ACTIVITY 74 198 2.086e-06 2.508e-05
387 GLYCOSYLATION 94 267 2.082e-06 2.508e-05
388 CYTOSKELETON ORGANIZATION 247 838 2.121e-06 2.544e-05
389 MAMMARY GLAND MORPHOGENESIS 23 40 2.128e-06 2.546e-05
390 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 65 168 2.183e-06 2.605e-05
391 EAR DEVELOPMENT 73 195 2.269e-06 2.694e-05
392 REGULATION OF MUSCLE SYSTEM PROCESS 73 195 2.269e-06 2.694e-05
393 NEURON MIGRATION 47 110 2.311e-06 2.737e-05
394 FOREBRAIN CELL MIGRATION 31 62 2.338e-06 2.761e-05
395 OSTEOBLAST DIFFERENTIATION 52 126 2.431e-06 2.863e-05
396 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 27 51 2.535e-06 2.979e-05
397 MULTICELLULAR ORGANISMAL SIGNALING 51 123 2.568e-06 3.002e-05
398 ENDOCRINE SYSTEM DEVELOPMENT 51 123 2.568e-06 3.002e-05
399 ORGAN GROWTH 33 68 2.611e-06 3.044e-05
400 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 43 98 2.65e-06 3.076e-05
401 CEREBRAL CORTEX CELL MIGRATION 24 43 2.651e-06 3.076e-05
402 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 269 926 2.681e-06 3.103e-05
403 CANONICAL WNT SIGNALING PATHWAY 42 95 2.718e-06 3.124e-05
404 ENDODERM DEVELOPMENT 34 71 2.708e-06 3.124e-05
405 REGIONALIZATION 106 311 2.719e-06 3.124e-05
406 REGULATION OF BMP SIGNALING PATHWAY 36 77 2.83e-06 3.243e-05
407 RESPONSE TO ESTRADIOL 58 146 2.848e-06 3.256e-05
408 REGULATION OF POTASSIUM ION TRANSPORT 38 83 2.861e-06 3.263e-05
409 MAMMARY GLAND DUCT MORPHOGENESIS 18 28 2.99e-06 3.402e-05
410 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 74 200 3.205e-06 3.638e-05
411 STRIATED MUSCLE CELL DIFFERENTIATION 66 173 3.228e-06 3.645e-05
412 SIGNAL RELEASE 66 173 3.228e-06 3.645e-05
413 NEGATIVE REGULATION OF TRANSPORT 146 458 3.267e-06 3.681e-05
414 REGULATION OF CHEMOTAXIS 68 180 3.443e-06 3.87e-05
415 NEGATIVE REGULATION OF CELL CYCLE 139 433 3.688e-06 4.135e-05
416 REGULATION OF PROTEIN SECRETION 127 389 3.743e-06 4.186e-05
417 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 309 1087 3.773e-06 4.21e-05
418 ANTERIOR POSTERIOR PATTERN SPECIFICATION 72 194 3.809e-06 4.23e-05
419 CELL SUBSTRATE JUNCTION ASSEMBLY 23 41 3.806e-06 4.23e-05
420 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 33 69 3.917e-06 4.34e-05
421 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 39 87 4.037e-06 4.399e-05
422 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 39 87 4.037e-06 4.399e-05
423 VIRAL ENTRY INTO HOST CELL 39 87 4.037e-06 4.399e-05
424 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 39 87 4.037e-06 4.399e-05
425 MOVEMENT IN HOST ENVIRONMENT 39 87 4.037e-06 4.399e-05
426 ENTRY INTO HOST 39 87 4.037e-06 4.399e-05
427 ENTRY INTO HOST CELL 39 87 4.037e-06 4.399e-05
428 CYTOKINESIS 38 84 4.087e-06 4.443e-05
429 REGULATION OF MUSCLE ORGAN DEVELOPMENT 44 103 4.829e-06 5.237e-05
430 GASTRULATION 60 155 5.174e-06 5.599e-05
431 POSITIVE REGULATION OF CATABOLIC PROCESS 128 395 5.226e-06 5.642e-05
432 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 22 39 5.462e-06 5.883e-05
433 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 59 152 5.586e-06 6.002e-05
434 REGULATION OF ORGAN GROWTH 34 73 5.886e-06 6.31e-05
435 FORMATION OF PRIMARY GERM LAYER 46 110 5.941e-06 6.34e-05
436 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 116 352 5.932e-06 6.34e-05
437 ORGAN FORMATION 20 34 6.114e-06 6.51e-05
438 EYE MORPHOGENESIS 54 136 6.278e-06 6.67e-05
439 REGULATION OF EPITHELIAL CELL MIGRATION 63 166 6.506e-06 6.895e-05
440 MUSCLE ORGAN DEVELOPMENT 95 277 6.527e-06 6.903e-05
441 REGULATION OF PROTEIN IMPORT 68 183 6.654e-06 7.02e-05
442 REGULATION OF BLOOD CIRCULATION 100 295 6.694e-06 7.047e-05
443 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 53 133 6.728e-06 7.066e-05
444 REGULATION OF NEUROTRANSMITTER LEVELS 70 190 6.918e-06 7.25e-05
445 REGULATION OF IMMUNE SYSTEM PROCESS 386 1403 7.508e-06 7.851e-05
446 CARDIAC MUSCLE CELL ACTION POTENTIAL 21 37 7.832e-06 8.17e-05
447 EPITHELIAL CELL PROLIFERATION 39 89 7.896e-06 8.219e-05
448 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 98 289 8.099e-06 8.412e-05
449 AMINO ACID TRANSPORT 50 124 8.218e-06 8.517e-05
450 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 57 147 8.282e-06 8.564e-05
451 SUBSTRATE DEPENDENT CELL MIGRATION 17 27 8.564e-06 8.836e-05
452 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 25 48 8.705e-06 8.961e-05
453 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 64 171 9.357e-06 9.611e-05
454 REGENERATION 61 161 9.616e-06 9.855e-05
455 LIPID PHOSPHORYLATION 42 99 9.677e-06 9.896e-05
456 MULTICELLULAR ORGANISM METABOLIC PROCESS 40 93 1.051e-05 0.0001073
457 REGULATION OF ENDOCYTOSIS 72 199 1.07e-05 0.0001087
458 ORGANELLE LOCALIZATION 132 415 1.069e-05 0.0001087
459 RESPONSE TO PEPTIDE 129 404 1.087e-05 0.0001101
460 TISSUE REMODELING 38 87 1.126e-05 0.0001139
461 STEM CELL PROLIFERATION 29 60 1.15e-05 0.0001158
462 CHONDROCYTE DIFFERENTIATION 29 60 1.15e-05 0.0001158
463 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 37 84 1.158e-05 0.0001164
464 LUNG CELL DIFFERENTIATION 16 25 1.173e-05 0.0001176
465 LENS DEVELOPMENT IN CAMERA TYPE EYE 31 66 1.212e-05 0.0001212
466 PROTEIN N LINKED GLYCOSYLATION 34 75 1.221e-05 0.0001217
467 OSTEOCLAST DIFFERENTIATION 18 30 1.222e-05 0.0001217
468 SYNAPSE ASSEMBLY 32 69 1.225e-05 0.0001218
469 PLATELET ACTIVATION 55 142 1.228e-05 0.0001219
470 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 90 263 1.243e-05 0.000123
471 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 70 193 1.281e-05 0.0001265
472 PROTEIN SECRETION 47 116 1.302e-05 0.0001284
473 REGULATION OF JNK CASCADE 60 159 1.309e-05 0.0001287
474 POSITIVE REGULATION OF CELL ADHESION 121 376 1.343e-05 0.0001318
475 GLOMERULUS DEVELOPMENT 25 49 1.395e-05 0.0001361
476 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 25 49 1.395e-05 0.0001361
477 CARDIAC SEPTUM MORPHOGENESIS 25 49 1.395e-05 0.0001361
478 RESPONSE TO BMP 40 94 1.431e-05 0.0001391
479 CELLULAR RESPONSE TO BMP STIMULUS 40 94 1.431e-05 0.0001391
480 CELL PROJECTION ASSEMBLY 90 264 1.47e-05 0.0001425
481 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 11 14 1.491e-05 0.0001443
482 REGULATION OF STEM CELL PROLIFERATION 38 88 1.551e-05 0.0001497
483 CRANIAL SKELETAL SYSTEM DEVELOPMENT 27 55 1.597e-05 0.0001539
484 EPHRIN RECEPTOR SIGNALING PATHWAY 37 85 1.605e-05 0.0001543
485 LUNG ALVEOLUS DEVELOPMENT 22 41 1.617e-05 0.0001551
486 CARDIAC CONDUCTION 36 82 1.654e-05 0.0001583
487 REGULATION OF RECEPTOR ACTIVITY 47 117 1.701e-05 0.0001626
488 MEMBRANE DEPOLARIZATION 29 61 1.719e-05 0.0001629
489 VENTRICULAR SEPTUM MORPHOGENESIS 17 28 1.718e-05 0.0001629
490 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 29 61 1.719e-05 0.0001629
491 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 29 61 1.719e-05 0.0001629
492 PANCREAS DEVELOPMENT 33 73 1.755e-05 0.0001653
493 REGULATION OF PLASMA MEMBRANE ORGANIZATION 33 73 1.755e-05 0.0001653
494 MICROTUBULE BASED MOVEMENT 73 205 1.753e-05 0.0001653
495 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 31 67 1.767e-05 0.0001661
496 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 68 188 1.873e-05 0.0001757
497 CELL CYCLE 361 1316 1.973e-05 0.0001848
498 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 48 121 2.061e-05 0.0001926
499 PROTEIN COMPLEX SUBUNIT ORGANIZATION 413 1527 2.079e-05 0.0001939
500 ANION TRANSPORT 155 507 2.152e-05 0.0002003
501 REGULATION OF ADHERENS JUNCTION ORGANIZATION 25 50 2.19e-05 0.000203
502 ENDODERM FORMATION 25 50 2.19e-05 0.000203
503 POSITIVE REGULATION OF CELL GROWTH 56 148 2.283e-05 0.0002106
504 MYELOID CELL DIFFERENTIATION 68 189 2.283e-05 0.0002106
505 POSITIVE REGULATION OF CELL CYCLE 108 332 2.286e-05 0.0002106
506 MESONEPHRIC TUBULE MORPHOGENESIS 26 53 2.32e-05 0.0002134
507 NEGATIVE CHEMOTAXIS 21 39 2.345e-05 0.0002152
508 REGULATION OF AUTOPHAGY 85 249 2.366e-05 0.0002167
509 REGULATION OF CELL PROJECTION ASSEMBLY 58 155 2.413e-05 0.0002205
510 REGULATION OF DENDRITIC SPINE DEVELOPMENT 27 56 2.42e-05 0.0002208
511 ACTOMYOSIN STRUCTURE ORGANIZATION 34 77 2.426e-05 0.0002209
512 CARDIAC MUSCLE CELL DIFFERENTIATION 33 74 2.481e-05 0.0002254
513 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 29 62 2.532e-05 0.0002297
514 POSITIVE REGULATION OF MAP KINASE ACTIVITY 73 207 2.553e-05 0.0002311
515 REGULATION OF HEART GROWTH 22 42 2.669e-05 0.0002411
516 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 39 93 2.732e-05 0.0002463
517 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 13 19 2.795e-05 0.0002516
518 POSITIVE REGULATION OF PROTEOLYSIS 116 363 2.832e-05 0.0002544
519 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 98 297 2.849e-05 0.0002554
520 POSITIVE REGULATION OF SODIUM ION TRANSPORT 19 34 2.865e-05 0.0002558
521 REGULATION OF MESENCHYMAL CELL PROLIFERATION 19 34 2.865e-05 0.0002558
522 POSITIVE REGULATION OF ION TRANSPORT 81 236 2.922e-05 0.0002601
523 TUBE FORMATION 50 129 2.923e-05 0.0002601
524 FEMALE SEX DIFFERENTIATION 46 116 3.067e-05 0.0002723
525 INORGANIC ION TRANSMEMBRANE TRANSPORT 174 583 3.142e-05 0.0002785
526 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 41 100 3.259e-05 0.0002883
527 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 17 29 3.272e-05 0.0002889
528 REGULATION OF ANOIKIS 15 24 3.347e-05 0.0002944
529 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 15 24 3.347e-05 0.0002944
530 ARTERY MORPHOGENESIS 25 51 3.373e-05 0.0002961
531 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 20 37 3.401e-05 0.000298
532 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 44 110 3.523e-05 0.0003082
533 NEGATIVE REGULATION OF ANOIKIS 12 17 3.585e-05 0.0003123
534 INTESTINAL EPITHELIAL CELL DIFFERENTIATION 12 17 3.585e-05 0.0003123
535 FORELIMB MORPHOGENESIS 21 40 3.882e-05 0.0003364
536 ENDODERMAL CELL DIFFERENTIATION 21 40 3.882e-05 0.0003364
537 REGULATION OF NEURON DEATH 85 252 3.879e-05 0.0003364
538 LEUKOCYTE ACTIVATION 129 414 3.936e-05 0.0003405
539 POSITIVE REGULATION OF BINDING 49 127 4.017e-05 0.0003467
540 CELL CYCLE ARREST 57 154 4.053e-05 0.0003492
541 REGULATION OF NEURON APOPTOTIC PROCESS 68 192 4.065e-05 0.0003496
542 CELLULAR RESPONSE TO PEPTIDE 91 274 4.106e-05 0.0003525
543 REGULATION OF PEPTIDE TRANSPORT 86 256 4.14e-05 0.0003548
544 REGULATION OF EMBRYONIC DEVELOPMENT 45 114 4.25e-05 0.0003635
545 CAMERA TYPE EYE MORPHOGENESIS 41 101 4.292e-05 0.0003664
546 REGULATION OF PROTEIN BINDING 61 168 4.305e-05 0.0003669
547 CELLULAR RESPONSE TO ACID CHEMICAL 63 175 4.385e-05 0.000373
548 PROTEIN OLIGOMERIZATION 134 434 4.549e-05 0.0003863
549 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 53 141 4.594e-05 0.0003894
550 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 78 228 4.607e-05 0.0003898
551 DENDRITE DEVELOPMENT 34 79 4.633e-05 0.0003899
552 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 14 22 4.623e-05 0.0003899
553 BONE MORPHOGENESIS 34 79 4.633e-05 0.0003899
554 POSITIVE REGULATION OF HEART GROWTH 16 27 4.657e-05 0.0003911
555 LEARNING 50 131 4.692e-05 0.0003927
556 RETINA DEVELOPMENT IN CAMERA TYPE EYE 50 131 4.692e-05 0.0003927
557 PEPTIDYL TYROSINE MODIFICATION 66 186 4.895e-05 0.0004089
558 NEUROTRANSMITTER TRANSPORT 57 155 5.007e-05 0.0004175
559 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 31 70 5.097e-05 0.0004242
560 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 30 67 5.204e-05 0.0004324
561 NEGATIVE REGULATION OF GROWTH 80 236 5.315e-05 0.0004408
562 CELL GROWTH 51 135 5.433e-05 0.0004498
563 INTESTINAL EPITHELIAL CELL DEVELOPMENT 9 11 5.578e-05 0.000461
564 AMINOGLYCAN METABOLIC PROCESS 60 166 5.761e-05 0.0004753
565 RESPONSE TO ENDOPLASMIC RETICULUM STRESS 79 233 5.848e-05 0.0004816
566 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 17 30 5.954e-05 0.0004895
567 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 47 122 5.967e-05 0.0004896
568 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 40 99 5.998e-05 0.0004913
569 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 21 41 6.26e-05 0.000511
570 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 21 41 6.26e-05 0.000511
571 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 13 20 6.32e-05 0.000515
572 NEGATIVE REGULATION OF CELL GROWTH 61 170 6.407e-05 0.0005198
573 MYELOID LEUKOCYTE DIFFERENTIATION 39 96 6.395e-05 0.0005198
574 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 49 129 6.413e-05 0.0005198
575 CELLULAR RESPONSE TO OXIDATIVE STRESS 65 184 6.483e-05 0.0005246
576 DEVELOPMENTAL CELL GROWTH 33 77 6.591e-05 0.0005324
577 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 15 25 6.608e-05 0.0005329
578 REGULATION OF DENDRITE MORPHOGENESIS 32 74 6.853e-05 0.0005517
579 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 18 33 7.162e-05 0.0005745
580 NEGATIVE REGULATION OF JNK CASCADE 18 33 7.162e-05 0.0005745
581 CELL CYCLE PROCESS 298 1081 7.21e-05 0.0005774
582 ENDOTHELIUM DEVELOPMENT 37 90 7.227e-05 0.0005778
583 NEGATIVE REGULATION OF AXONOGENESIS 29 65 7.474e-05 0.0005965
584 APOPTOTIC SIGNALING PATHWAY 94 289 7.525e-05 0.0005995
585 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 25 53 7.583e-05 0.0006011
586 CYTOSOLIC CALCIUM ION TRANSPORT 25 53 7.583e-05 0.0006011
587 CELLULAR RESPONSE TO AMINO ACID STIMULUS 25 53 7.583e-05 0.0006011
588 RESPONSE TO OXIDATIVE STRESS 111 352 7.689e-05 0.0006085
589 NEGATIVE REGULATION OF NEURON DEATH 61 171 7.779e-05 0.0006145
590 SEMAPHORIN PLEXIN SIGNALING PATHWAY 19 36 8.229e-05 0.000649
591 ESTABLISHMENT OF LOCALIZATION BY MOVEMENT ALONG MICROTUBULE 39 97 8.373e-05 0.0006592
592 PHOSPHOLIPID METABOLIC PROCESS 114 364 8.513e-05 0.0006691
593 REGULATION OF HEART CONTRACTION 75 221 8.576e-05 0.0006718
594 REGULATION OF KERATINOCYTE PROLIFERATION 16 28 8.576e-05 0.0006718
595 REGULATION OF AXON GUIDANCE 20 39 9.129e-05 0.0007115
596 ANATOMICAL STRUCTURE MATURATION 20 39 9.129e-05 0.0007115
597 CYTOSKELETON DEPENDENT CYTOKINESIS 20 39 9.129e-05 0.0007115
598 DEVELOPMENTAL MATURATION 67 193 9.274e-05 0.0007216
599 REGULATION OF EXOCYTOSIS 65 186 9.366e-05 0.0007266
600 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 32 75 9.37e-05 0.0007266
601 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 63 179 9.415e-05 0.0007289
602 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 176 602 9.672e-05 0.0007476
603 ENDOTHELIAL CELL DIFFERENTIATION 31 72 9.766e-05 0.0007536
604 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 70 204 9.88e-05 0.0007611
605 RESPONSE TO INORGANIC SUBSTANCE 144 479 0.0001006 0.0007737
606 EXOCRINE SYSTEM DEVELOPMENT 22 45 0.000104 0.0007983
607 REGULATION OF HORMONE SECRETION 86 262 0.0001044 0.0007992
608 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 78 233 0.0001045 0.0007992
609 REGULATION OF CARDIAC MUSCLE CONTRACTION 29 66 0.0001046 0.0007992
610 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 23 48 0.0001078 0.0008219
611 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 118 381 0.0001088 0.0008278
612 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 39 98 0.0001089 0.0008278
613 ORGANELLE TRANSPORT ALONG MICROTUBULE 27 60 0.0001094 0.0008305
614 NEURAL CREST CELL MIGRATION 24 51 0.00011 0.0008323
615 SEX DIFFERENTIATION 87 266 0.0001099 0.0008323
616 APOPTOTIC MITOCHONDRIAL CHANGES 26 57 0.0001107 0.0008359
617 NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 11 16 0.0001127 0.0008457
618 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 115 370 0.0001126 0.0008457
619 NEURON CELL CELL ADHESION 11 16 0.0001127 0.0008457
620 MAGNESIUM ION TRANSMEMBRANE TRANSPORT 11 16 0.0001127 0.0008457
621 PROTEIN HOMOOLIGOMERIZATION 82 248 0.0001134 0.0008498
622 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 18 34 0.00012 0.0008931
623 ADHERENS JUNCTION ASSEMBLY 18 34 0.00012 0.0008931
624 HEART VALVE DEVELOPMENT 18 34 0.00012 0.0008931
625 CAMP METABOLIC PROCESS 18 34 0.00012 0.0008931
626 SYNAPTIC SIGNALING 129 424 0.0001281 0.000952
627 RENAL SYSTEM PROCESS 40 102 0.0001306 0.0009692
628 CHONDROCYTE DEVELOPMENT 13 21 0.0001313 0.00097
629 LIPID TRANSLOCATION 13 21 0.0001313 0.00097
630 ACIDIC AMINO ACID TRANSPORT 13 21 0.0001313 0.00097
631 MUSCLE SYSTEM PROCESS 91 282 0.0001331 0.0009816
632 POST EMBRYONIC DEVELOPMENT 36 89 0.0001335 0.000983
633 LOCOMOTORY BEHAVIOR 63 181 0.0001355 0.0009961
634 AGING 86 264 0.00014 0.001027
635 ORGANIC ANION TRANSPORT 119 387 0.0001419 0.00104
636 NEGATIVE REGULATION OF JUN KINASE ACTIVITY 10 14 0.0001448 0.001059
637 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 28 64 0.0001498 0.001094
638 EMBRYONIC DIGIT MORPHOGENESIS 27 61 0.0001541 0.001122
639 MULTICELLULAR ORGANISMAL HOMEOSTASIS 88 272 0.0001539 0.001122
640 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 22 46 0.0001568 0.00114
641 L AMINO ACID TRANSPORT 26 58 0.0001575 0.001142
642 EMBRYONIC PATTERN SPECIFICATION 26 58 0.0001575 0.001142
643 ACTIVATION OF MAPKK ACTIVITY 24 52 0.0001606 0.001162
644 REGULATION OF MUSCLE CONTRACTION 53 147 0.0001625 0.001174
645 EMBRYONIC FORELIMB MORPHOGENESIS 17 32 0.000175 0.001261
646 ADIPOSE TISSUE DEVELOPMENT 17 32 0.000175 0.001261
647 ORGANOPHOSPHATE METABOLIC PROCESS 246 885 0.0001755 0.001262
648 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 31 74 0.0001797 0.00129
649 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 12 19 0.0001834 0.001315
650 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 67 197 0.0001847 0.001322
651 ADHERENS JUNCTION ORGANIZATION 30 71 0.000189 0.001351
652 RESPONSE TO METAL ION 104 333 0.0001907 0.001361
653 REGULATION OF PROTEIN TARGETING 97 307 0.0001942 0.001384
654 RESPONSE TO TRANSITION METAL NANOPARTICLE 53 148 0.0001979 0.001408
655 HEMOSTASIS 98 311 0.0002012 0.001429
656 REGULATION OF HORMONE LEVELS 142 478 0.0002027 0.001438
657 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 19 38 0.00021 0.001481
658 REGULATION OF ACTION POTENTIAL 19 38 0.00021 0.001481
659 CALCIUM ION TRANSPORT 74 223 0.00021 0.001481
660 POSITIVE REGULATION OF ORGAN GROWTH 19 38 0.00021 0.001481
661 POSITIVE REGULATION OF PROTEIN IMPORT 40 104 0.0002127 0.001497
662 RESPONSE TO ACID CHEMICAL 100 319 0.0002154 0.001514
663 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 15 27 0.0002194 0.001522
664 REGULATION OF MUSCLE CELL DIFFERENTIATION 54 152 0.0002187 0.001522
665 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 15 27 0.0002194 0.001522
666 INTRINSIC APOPTOTIC SIGNALING PATHWAY 54 152 0.0002187 0.001522
667 REGULATION OF CATENIN IMPORT INTO NUCLEUS 15 27 0.0002194 0.001522
668 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 15 27 0.0002194 0.001522
669 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 15 27 0.0002194 0.001522
670 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 15 27 0.0002194 0.001522
671 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 72 216 0.000218 0.001522
672 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 90 282 0.0002213 0.001526
673 REGULATION OF MEMBRANE DEPOLARIZATION 20 41 0.0002211 0.001526
674 PROSTATE GLAND DEVELOPMENT 20 41 0.0002211 0.001526
675 LACTATION 20 41 0.0002211 0.001526
676 CARBOHYDRATE METABOLIC PROCESS 189 662 0.0002222 0.00153
677 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 70 209 0.0002257 0.001549
678 REGULATION OF PEPTIDE SECRETION 70 209 0.0002257 0.001549
679 IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 25 56 0.0002268 0.001554
680 REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 21 44 0.0002282 0.001562
681 LYMPHOCYTE ACTIVATION 106 342 0.0002292 0.001566
682 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 24 53 0.0002307 0.001572
683 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 24 53 0.0002307 0.001572
684 CELLULAR RESPONSE TO CAMP 23 50 0.0002326 0.00158
685 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 23 50 0.0002326 0.00158
686 NEURAL TUBE DEVELOPMENT 53 149 0.0002402 0.001627
687 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 71 213 0.00024 0.001627
688 ESTABLISHMENT OF CELL POLARITY 35 88 0.0002429 0.001643
689 VESICLE LOCALIZATION 74 224 0.0002448 0.001653
690 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 38 98 0.0002493 0.001681
691 REGULATION OF NEURON MIGRATION 16 30 0.0002556 0.001716
692 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 16 30 0.0002556 0.001716
693 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 16 30 0.0002556 0.001716
694 NEGATIVE REGULATION OF KINASE ACTIVITY 81 250 0.0002609 0.001749
695 CELLULAR RESPONSE TO ALCOHOL 43 115 0.0002617 0.001752
696 CELLULAR RESPONSE TO INSULIN STIMULUS 52 146 0.0002637 0.001763
697 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 54 153 0.0002643 0.001764
698 CARBOHYDRATE TRANSPORT 37 95 0.0002695 0.001797
699 POSITIVE REGULATION OF SECRETION 113 370 0.0002757 0.001835
700 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 72 218 0.0002969 0.001973
701 ANION TRANSMEMBRANE TRANSPORT 81 251 0.0003006 0.001995
702 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 18 36 0.0003072 0.00203
703 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 26 60 0.0003068 0.00203
704 POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS 18 36 0.0003072 0.00203
705 RESPONSE TO CARBOHYDRATE 58 168 0.0003111 0.002054
706 GLIAL CELL DEVELOPMENT 31 76 0.0003184 0.002096
707 PROTEIN DEPOLYMERIZATION 14 25 0.0003189 0.002096
708 HISTONE PHOSPHORYLATION 14 25 0.0003189 0.002096
709 VESICLE CYTOSKELETAL TRAFFICKING 19 39 0.0003228 0.002113
710 TRABECULA MORPHOGENESIS 19 39 0.0003228 0.002113
711 LONG TERM SYNAPTIC POTENTIATION 19 39 0.0003228 0.002113
712 MONOSACCHARIDE TRANSPORT 24 54 0.0003266 0.002134
713 DENDRITE MORPHOGENESIS 20 42 0.0003325 0.002167
714 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 20 42 0.0003325 0.002167
715 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 59 172 0.0003363 0.002189
716 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 22 48 0.0003369 0.002189
717 EMBRYONIC HEART TUBE DEVELOPMENT 30 73 0.0003387 0.002198
718 MICROTUBULE BASED PROCESS 152 522 0.0003412 0.002211
719 EPITHELIAL CELL MATURATION 10 15 0.0003456 0.002236
720 AMELOGENESIS 12 20 0.0003637 0.002347
721 REGULATION OF MACROPHAGE DIFFERENTIATION 12 20 0.0003637 0.002347
722 REGULATION OF CIRCADIAN RHYTHM 39 103 0.0003683 0.002371
723 POSITIVE REGULATION OF CHEMOTAXIS 44 120 0.0003684 0.002371
724 PEPTIDYL TYROSINE DEPHOSPHORYLATION 38 100 0.0004006 0.002575
725 MITOTIC CYTOKINESIS 16 31 0.0004173 0.002678
726 ANTIGEN PROCESSING AND PRESENTATION 70 213 0.0004189 0.002685
727 PROTEIN STABILIZATION 47 131 0.0004201 0.002686
728 POSITIVE REGULATION OF STEM CELL PROLIFERATION 26 61 0.0004202 0.002686
729 PHOSPHOLIPID BIOSYNTHETIC PROCESS 76 235 0.0004214 0.00269
730 REGULATION OF SEQUESTERING OF CALCIUM ION 40 107 0.0004234 0.002691
731 NEGATIVE REGULATION OF MAPK CASCADE 51 145 0.0004229 0.002691
732 AMINOGLYCAN BIOSYNTHETIC PROCESS 40 107 0.0004234 0.002691
733 POSITIVE REGULATION OF ENDOCYTOSIS 42 114 0.0004408 0.002798
734 CELL CELL JUNCTION ASSEMBLY 30 74 0.0004472 0.002831
735 RESPONSE TO CYTOKINE 200 714 0.000447 0.002831
736 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 24 55 0.0004557 0.002877
737 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 24 55 0.0004557 0.002877
738 PROTEIN ALPHA 1 2 DEMANNOSYLATION 9 13 0.0004609 0.00289
739 MAGNESIUM ION TRANSPORT 9 13 0.0004609 0.00289
740 PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION 9 13 0.0004609 0.00289
741 PROTEIN DEMANNOSYLATION 9 13 0.0004609 0.00289
742 PERIPHERAL NERVOUS SYSTEM NEURON DEVELOPMENT 9 13 0.0004609 0.00289
743 RESPONSE TO INCREASED OXYGEN LEVELS 13 23 0.0004634 0.002891
744 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 13 23 0.0004634 0.002891
745 RESPONSE TO HYPEROXIA 13 23 0.0004634 0.002891
746 INNERVATION 13 23 0.0004634 0.002891
747 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 48 135 0.0004647 0.002895
748 REGULATION OF MEMBRANE LIPID DISTRIBUTION 18 37 0.0004719 0.00292
749 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 18 37 0.0004719 0.00292
750 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 18 37 0.0004719 0.00292
751 ACTIN FILAMENT ORGANIZATION 59 174 0.0004717 0.00292
752 IMPORT INTO CELL 18 37 0.0004719 0.00292
753 DICARBOXYLIC ACID TRANSPORT 29 71 0.000477 0.002944
754 BODY FLUID SECRETION 29 71 0.000477 0.002944
755 HINDBRAIN MORPHOGENESIS 19 40 0.0004848 0.002988
756 GLYCEROLIPID METABOLIC PROCESS 108 356 0.0004858 0.00299
757 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 238 867 0.000488 0.002999
758 MORPHOGENESIS OF AN EPITHELIAL SHEET 20 43 0.0004898 0.003007
759 PROTEIN TARGETING 121 406 0.0005013 0.003073
760 REGULATION OF CELL JUNCTION ASSEMBLY 28 68 0.0005075 0.003107
761 REGULATION OF COLLATERAL SPROUTING 11 18 0.0005181 0.003159
762 RESPONSE TO EXTRACELLULAR STIMULUS 130 441 0.000518 0.003159
763 CENTROSOME LOCALIZATION 11 18 0.0005181 0.003159
764 REGULATION OF CATION CHANNEL ACTIVITY 34 88 0.0005562 0.003387
765 RAS PROTEIN SIGNAL TRANSDUCTION 50 143 0.0005593 0.003402
766 CARDIAC VENTRICLE MORPHOGENESIS 26 62 0.0005689 0.003451
767 EMBRYONIC HEART TUBE MORPHOGENESIS 26 62 0.0005689 0.003451
768 REGULATION OF LIPID METABOLIC PROCESS 88 282 0.0005839 0.003538
769 BONE TRABECULA MORPHOGENESIS 8 11 0.0005937 0.003578
770 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 11 0.0005937 0.003578
771 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 8 11 0.0005937 0.003578
772 NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 8 11 0.0005937 0.003578
773 RESPONSE TO AMINO ACID 41 112 0.0005955 0.003584
774 POTASSIUM ION TRANSPORT 53 154 0.0005993 0.003603
775 PROTEIN DEPHOSPHORYLATION 63 190 0.0006081 0.003651
776 STEM CELL DIVISION 15 29 0.0006122 0.003661
777 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 15 29 0.0006122 0.003661
778 CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION 15 29 0.0006122 0.003661
779 NEGATIVE REGULATION OF CELL ADHESION 72 223 0.0006189 0.003697
780 CIRCULATORY SYSTEM PROCESS 110 366 0.0006308 0.003763
781 RESPONSE TO HYDROGEN PEROXIDE 40 109 0.0006519 0.003884
782 SALIVARY GLAND DEVELOPMENT 16 32 0.0006596 0.00391
783 METANEPHRIC NEPHRON DEVELOPMENT 16 32 0.0006596 0.00391
784 POSITIVE REGULATION OF DENDRITE MORPHOGENESIS 16 32 0.0006596 0.00391
785 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 16 32 0.0006596 0.00391
786 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 42 116 0.0006676 0.003952
787 CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS 78 246 0.0006921 0.004092
788 REGULATION OF STRIATED MUSCLE CONTRACTION 31 79 0.0007037 0.004155
789 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 20 44 0.0007078 0.004174
790 RESPONSE TO REACTIVE OXYGEN SPECIES 63 191 0.0007091 0.004177
791 SYNAPTIC VESICLE LOCALIZATION 39 106 0.0007136 0.004182
792 AORTA DEVELOPMENT 19 41 0.0007126 0.004182
793 REGULATION OF GLUCOSE METABOLIC PROCESS 39 106 0.0007136 0.004182
794 EXOCYTOSIS 95 310 0.0007118 0.004182
795 REGULATION OF PROTEIN COMPLEX ASSEMBLY 112 375 0.0007279 0.00426
796 OVULATION CYCLE 41 113 0.0007321 0.004273
797 REGULATION OF CLATHRIN MEDIATED ENDOCYTOSIS 10 16 0.0007337 0.004273
798 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 10 16 0.0007337 0.004273
799 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 16 0.0007337 0.004273
800 POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 13 24 0.0008016 0.004645
801 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 13 24 0.0008016 0.004645
802 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 13 24 0.0008016 0.004645
803 CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT 13 24 0.0008016 0.004645
804 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 40 110 0.0008027 0.004646
805 MAINTENANCE OF LOCATION 48 138 0.0008125 0.004697
806 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 42 117 0.0008158 0.00471
807 G1 DNA DAMAGE CHECKPOINT 29 73 0.0008175 0.004713
808 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 46 131 0.0008197 0.00472
809 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 44 124 0.0008211 0.004723
810 POST GOLGI VESICLE MEDIATED TRANSPORT 32 83 0.0008321 0.00478
811 REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 85 274 0.000875 0.00502
812 REGULATION OF MEMBRANE PERMEABILITY 28 70 0.0008787 0.005029
813 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 28 70 0.0008787 0.005029
814 RESPONSE TO DRUG 126 431 0.0008871 0.005071
815 SYNAPTIC VESICLE CYCLE 34 90 0.0008901 0.005075
816 ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 34 90 0.0008901 0.005075
817 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 47 135 0.0008946 0.005095
818 HIPPO SIGNALING 14 27 0.0008996 0.005117
819 REGULATION OF LIPID BIOSYNTHETIC PROCESS 45 128 0.0009019 0.005118
820 MUSCLE CELL DEVELOPMENT 45 128 0.0009019 0.005118
821 SECOND MESSENGER MEDIATED SIGNALING 54 160 0.0009042 0.005124
822 SKIN DEVELOPMENT 68 211 0.0009097 0.005149
823 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 36 97 0.0009338 0.005279
824 HOMOTYPIC CELL CELL ADHESION 22 51 0.0009374 0.005293
825 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 50 146 0.0009529 0.005374
826 MEMBRANE BIOGENESIS 15 30 0.0009688 0.005428
827 SMOOTH MUSCLE CELL DIFFERENTIATION 15 30 0.0009688 0.005428
828 NEGATIVE REGULATION OF CELL MATRIX ADHESION 15 30 0.0009688 0.005428
829 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 15 30 0.0009688 0.005428
830 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 33 87 0.0009694 0.005428
831 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 15 30 0.0009688 0.005428
832 REGULATION OF CELL SHAPE 48 139 0.0009715 0.005433
833 REGULATION OF SODIUM ION TRANSPORT 30 77 0.0009767 0.005455
834 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 11 19 0.0009782 0.005458
835 LUNG MORPHOGENESIS 20 45 0.001005 0.005585
836 POSITIVE REGULATION OF RECEPTOR ACTIVITY 20 45 0.001005 0.005585
837 ENDOCHONDRAL BONE MORPHOGENESIS 20 45 0.001005 0.005585
838 NEURON RECOGNITION 16 33 0.001012 0.005607
839 NUCLEOTIDE SUGAR METABOLIC PROCESS 16 33 0.001012 0.005607
840 EMBRYONIC EYE MORPHOGENESIS 16 33 0.001012 0.005607
841 RESPONSE TO RADIATION 121 413 0.001015 0.005618
842 SULFUR COMPOUND METABOLIC PROCESS 107 359 0.001019 0.005629
843 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 9 14 0.00103 0.005633
844 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 9 14 0.00103 0.005633
845 CYTOKINETIC PROCESS 9 14 0.00103 0.005633
846 POSITIVE REGULATION OF DNA BINDING 19 42 0.001027 0.005633
847 ERBB2 SIGNALING PATHWAY 18 39 0.001037 0.005633
848 ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE 82 264 0.001024 0.005633
849 METANEPHRIC MESENCHYME DEVELOPMENT 9 14 0.00103 0.005633
850 OLFACTORY LOBE DEVELOPMENT 17 36 0.001034 0.005633
851 COCHLEA DEVELOPMENT 18 39 0.001037 0.005633
852 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 17 36 0.001034 0.005633
853 CELLULAR RESPONSE TO VITAMIN D 9 14 0.00103 0.005633
854 CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS 9 14 0.00103 0.005633
855 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 18 39 0.001037 0.005633
856 NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION 18 39 0.001037 0.005633
857 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 18 39 0.001037 0.005633
858 CELL DIVISION 133 460 0.001046 0.00567
859 NITROGEN COMPOUND TRANSPORT 145 507 0.001047 0.00567
860 RETROGRADE TRANSPORT ENDOSOME TO GOLGI 29 74 0.001056 0.005714
861 REGULATION OF MITOTIC CELL CYCLE 135 468 0.001064 0.005749
862 MUCOPOLYSACCHARIDE METABOLIC PROCESS 39 108 0.00108 0.005828
863 CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 43 122 0.001092 0.005887
864 MITOTIC CELL CYCLE 210 766 0.001093 0.005888
865 RESPONSE TO INSULIN 66 205 0.001103 0.005935
866 ORGANIC ACID TRANSPORT 81 261 0.001124 0.00604
867 O GLYCAN PROCESSING 24 58 0.001145 0.006139
868 RESPONSE TO LIGHT STIMULUS 86 280 0.001145 0.006139
869 ACTIVIN RECEPTOR SIGNALING PATHWAY 12 22 0.001176 0.006292
870 PROTEIN LOCALIZATION TO CELL SURFACE 12 22 0.001176 0.006292
871 EAR MORPHOGENESIS 40 112 0.001199 0.006405
872 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 42 119 0.001202 0.006411
873 REGULATION OF KIDNEY DEVELOPMENT 23 55 0.001213 0.006466
874 OVULATION CYCLE PROCESS 33 88 0.001217 0.006481
875 RESPONSE TO NUTRIENT 62 191 0.001221 0.006492
876 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 27 68 0.001229 0.006528
877 HORMONE TRANSPORT 30 78 0.001247 0.006607
878 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 30 78 0.001247 0.006607
879 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 54 162 0.001249 0.006611
880 ORGANELLE MEMBRANE FUSION 35 95 0.001268 0.006703
881 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 22 52 0.00128 0.006753
882 CELLULAR RESPONSE TO IONIZING RADIATION 22 52 0.00128 0.006753
883 NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION 70 221 0.001299 0.006845
884 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 39 109 0.001318 0.006937
885 MEMBRANE ASSEMBLY 13 25 0.001325 0.00694
886 CELLULAR RESPONSE TO TOXIC SUBSTANCE 13 25 0.001325 0.00694
887 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 13 25 0.001325 0.00694
888 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 13 25 0.001325 0.00694
889 POSITIVE REGULATION OF CELL CYCLE ARREST 32 85 0.001329 0.006954
890 ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 58 177 0.001342 0.007013
891 POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 29 75 0.001353 0.00705
892 SENSORY PERCEPTION OF PAIN 29 75 0.001353 0.00705
893 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 29 75 0.001353 0.00705
894 GLUCOSE HOMEOSTASIS 56 170 0.001402 0.007288
895 CARBOHYDRATE HOMEOSTASIS 56 170 0.001402 0.007288
896 REGULATION OF GLOMERULAR FILTRATION 8 12 0.001425 0.007346
897 HEMIDESMOSOME ASSEMBLY 8 12 0.001425 0.007346
898 LONG TERM MEMORY 14 28 0.001426 0.007346
899 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 8 12 0.001425 0.007346
900 EMBRYONIC CAMERA TYPE EYE FORMATION 8 12 0.001425 0.007346
901 RESPONSE TO MANGANESE ION 10 17 0.00142 0.007346
902 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 14 28 0.001426 0.007346
903 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 8 12 0.001425 0.007346
904 CYTOKINE PRODUCTION 42 120 0.001448 0.007439
905 TRANSITION METAL ION HOMEOSTASIS 38 106 0.001448 0.007439
906 FAT CELL DIFFERENTIATION 38 106 0.001448 0.007439
907 CRANIAL NERVE DEVELOPMENT 19 43 0.001452 0.007447
908 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 49 145 0.001473 0.007549
909 SCHWANN CELL DIFFERENTIATION 15 31 0.001486 0.007598
910 CELLULAR RESPONSE TO GLUCOSE STARVATION 15 31 0.001486 0.007598
911 ENDOCRINE PANCREAS DEVELOPMENT 18 40 0.00149 0.0076
912 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 18 40 0.00149 0.0076
913 LUNG EPITHELIUM DEVELOPMENT 16 34 0.001512 0.007649
914 POSITIVE REGULATION OF CATION CHANNEL ACTIVITY 17 37 0.001512 0.007649
915 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 16 34 0.001512 0.007649
916 RESPONSE TO FLUID SHEAR STRESS 16 34 0.001512 0.007649
917 RESPONSE TO NERVE GROWTH FACTOR 17 37 0.001512 0.007649
918 RENAL WATER HOMEOSTASIS 16 34 0.001512 0.007649
919 GLIAL CELL MIGRATION 17 37 0.001512 0.007649
920 AXON EXTENSION 17 37 0.001512 0.007649
921 SEGMENTATION 33 89 0.001519 0.007658
922 VASCULOGENESIS 24 59 0.001519 0.007658
923 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 33 89 0.001519 0.007658
924 RESPONSE TO TOXIC SUBSTANCE 75 241 0.00154 0.007755
925 SPECIFICATION OF SYMMETRY 41 117 0.001595 0.008025
926 RESPONSE TO KETONE 59 182 0.001634 0.008203
927 PROTEOLYSIS 317 1208 0.001634 0.008203
928 NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 113 387 0.001654 0.008294
929 REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 32 86 0.001661 0.008322
930 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 51 153 0.001675 0.008382
931 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 29 76 0.001719 0.008593
932 NEURON PROJECTION EXTENSION 22 53 0.001725 0.00861
933 RELAXATION OF MUSCLE 11 20 0.001729 0.008615
934 ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS 11 20 0.001729 0.008615
935 NOTCH SIGNALING PATHWAY 40 114 0.001757 0.008744
936 VESICLE ORGANIZATION 85 280 0.001778 0.00883
937 PROTEIN TARGETING TO MEMBRANE 52 157 0.001777 0.00883
938 REGULATION OF ERBB SIGNALING PATHWAY 31 83 0.001817 0.009011
939 NEURAL RETINA DEVELOPMENT 21 50 0.001827 0.009032
940 RESPONSE TO GAMMA RADIATION 21 50 0.001827 0.009032
941 VISUAL BEHAVIOR 21 50 0.001827 0.009032
942 RESPONSE TO OSMOTIC STRESS 25 63 0.001852 0.009146
943 NEGATIVE REGULATION OF MOLECULAR FUNCTION 285 1079 0.001861 0.009183
944 IN UTERO EMBRYONIC DEVELOPMENT 93 311 0.001868 0.009206
945 REGULATION OF MYELOID CELL DIFFERENTIATION 59 183 0.001886 0.009257
946 MIDBRAIN DEVELOPMENT 33 90 0.001883 0.009257
947 STEROID HORMONE MEDIATED SIGNALING PATHWAY 43 125 0.001885 0.009257
948 REGULATION OF GLIOGENESIS 33 90 0.001883 0.009257
949 REGULATION OF CALCIUM ION TRANSPORT 66 209 0.001904 0.009337
950 ORGANONITROGEN COMPOUND METABOLIC PROCESS 458 1796 0.001908 0.009343
951 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 37 104 0.001938 0.009484
952 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 79 258 0.001944 0.0095
953 PROTEIN TARGETING TO PLASMA MEMBRANE 12 23 0.001954 0.009522
954 REGULATION OF METANEPHROS DEVELOPMENT 12 23 0.001954 0.009522
955 REGULATION OF RESPIRATORY GASEOUS EXCHANGE 12 23 0.001954 0.009522
956 MULTI MULTICELLULAR ORGANISM PROCESS 67 213 0.001973 0.009605
957 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 24 60 0.001994 0.009693
958 POSITIVE REGULATION OF CELL CYCLE PROCESS 76 247 0.002025 0.009834
959 NEURAL PRECURSOR CELL PROLIFERATION 27 70 0.002033 0.009864
960 REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 9 15 0.002056 0.009957
961 CELL COMMUNICATION BY ELECTRICAL COUPLING 9 15 0.002056 0.009957
NumGOOverlapSizeP ValueAdj. P Value
1 ENZYME BINDING 583 1737 1.58e-27 1.468e-24
2 MACROMOLECULAR COMPLEX BINDING 474 1399 2.861e-23 1.329e-20
3 PROTEIN COMPLEX BINDING 331 935 1.238e-19 3.834e-17
4 PROTEIN KINASE ACTIVITY 239 640 1.521e-17 3.533e-15
5 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 231 629 4.947e-16 9.192e-14
6 CYTOSKELETAL PROTEIN BINDING 283 819 2.239e-15 3.466e-13
7 KINASE ACTIVITY 289 842 2.949e-15 3.475e-13
8 PROTEIN DOMAIN SPECIFIC BINDING 227 624 2.993e-15 3.475e-13
9 MOLECULAR FUNCTION REGULATOR 427 1353 5.402e-15 5.576e-13
10 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 135 328 4.523e-14 4.202e-12
11 KINASE BINDING 215 606 3.065e-13 2.589e-11
12 RECEPTOR SIGNALING PROTEIN ACTIVITY 82 172 4.751e-13 3.678e-11
13 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 128 315 6.169e-13 4.408e-11
14 RIBONUCLEOTIDE BINDING 545 1860 2.512e-12 1.667e-10
15 SMAD BINDING 44 72 2.902e-12 1.797e-10
16 CELL ADHESION MOLECULE BINDING 85 186 3.255e-12 1.89e-10
17 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 317 992 4.348e-12 2.376e-10
18 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 372 1199 4.718e-12 2.435e-10
19 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 47 81 7.453e-12 3.644e-10
20 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 129 329 9.868e-12 4.231e-10
21 IDENTICAL PROTEIN BINDING 373 1209 1.002e-11 4.231e-10
22 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 97 226 9.556e-12 4.231e-10
23 REGULATORY REGION NUCLEIC ACID BINDING 268 818 1.155e-11 4.665e-10
24 PROTEIN SERINE THREONINE KINASE ACTIVITY 163 445 1.369e-11 5.299e-10
25 ADENYL NUCLEOTIDE BINDING 449 1514 4.353e-11 1.617e-09
26 GROWTH FACTOR BINDING 61 123 5.748e-11 2.054e-09
27 RECEPTOR BINDING 436 1476 1.562e-10 5.375e-09
28 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 150 417 3.994e-10 1.325e-08
29 INTEGRIN BINDING 53 105 4.486e-10 1.437e-08
30 DOUBLE STRANDED DNA BINDING 246 764 5.42e-10 1.678e-08
31 ENZYME ACTIVATOR ACTIVITY 164 471 1.01e-09 3.026e-08
32 PHOSPHOLIPID BINDING 132 360 1.102e-09 3.198e-08
33 PHOSPHATIDYLINOSITOL BINDING 83 200 2.088e-09 5.879e-08
34 ACTIN BINDING 140 393 3.164e-09 8.645e-08
35 LIPID BINDING 213 657 4.23e-09 1.123e-07
36 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 193 588 7.889e-09 2.036e-07
37 PHOSPHATASE BINDING 69 162 1.313e-08 3.296e-07
38 TRANSCRIPTION FACTOR BINDING 174 524 1.712e-08 4.186e-07
39 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 35 64 2.87e-08 6.666e-07
40 CALCIUM ION BINDING 220 697 2.82e-08 6.666e-07
41 BETA CATENIN BINDING 42 84 3.999e-08 9.062e-07
42 SEQUENCE SPECIFIC DNA BINDING 308 1037 5.172e-08 1.144e-06
43 TUBULIN BINDING 101 273 5.742e-08 1.241e-06
44 TRANSPORTER ACTIVITY 369 1276 5.968e-08 1.26e-06
45 GTPASE BINDING 107 295 7.702e-08 1.59e-06
46 PROTEIN HOMODIMERIZATION ACTIVITY 224 722 9.824e-08 1.984e-06
47 MICROTUBULE BINDING 78 201 1.924e-07 3.802e-06
48 TRANSMEMBRANE TRANSPORTER ACTIVITY 294 997 2.158e-07 4.176e-06
49 INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 170 527 2.237e-07 4.241e-06
50 DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 67 167 3.275e-07 5.966e-06
51 GLYCOPROTEIN BINDING 46 101 3.25e-07 5.966e-06
52 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 107 303 3.587e-07 6.287e-06
53 CHROMATIN BINDING 144 435 3.523e-07 6.287e-06
54 PROTEIN PHOSPHATASE BINDING 52 120 4.036e-07 6.944e-06
55 CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 194 622 4.709e-07 7.954e-06
56 ENZYME REGULATOR ACTIVITY 282 959 5.006e-07 8.305e-06
57 UBIQUITIN LIKE PROTEIN LIGASE BINDING 95 264 6.09e-07 9.926e-06
58 MICROTUBULE MOTOR ACTIVITY 37 77 8.963e-07 1.436e-05
59 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 42 92 9.631e-07 1.516e-05
60 ION CHANNEL BINDING 48 111 1.194e-06 1.849e-05
61 PROTEIN DIMERIZATION ACTIVITY 328 1149 1.249e-06 1.902e-05
62 ZINC ION BINDING 329 1155 1.489e-06 2.231e-05
63 MOTOR ACTIVITY 54 131 1.64e-06 2.418e-05
64 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 83 228 1.789e-06 2.596e-05
65 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 36 76 1.926e-06 2.752e-05
66 SH3 DOMAIN BINDING 49 116 2.12e-06 2.984e-05
67 CALMODULIN BINDING 68 179 2.746e-06 3.808e-05
68 PROTEIN TYROSINE KINASE ACTIVITY 67 176 2.978e-06 4.069e-05
69 BINDING BRIDGING 66 173 3.228e-06 4.346e-05
70 PDZ DOMAIN BINDING 40 90 3.967e-06 5.265e-05
71 PROTEIN C TERMINUS BINDING 69 186 6.106e-06 7.989e-05
72 CHANNEL REGULATOR ACTIVITY 52 131 9.327e-06 0.0001203
73 PHOSPHATIDYLINOSITOL PHOSPHATE BINDING 47 116 1.302e-05 0.0001657
74 MAGNESIUM ION BINDING 71 199 2.107e-05 0.0002645
75 VOLTAGE GATED ION CHANNEL ACTIVITY 68 190 2.775e-05 0.0003438
76 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 143 464 2.846e-05 0.0003479
77 GROWTH FACTOR RECEPTOR BINDING 50 129 2.923e-05 0.0003527
78 CORE PROMOTER PROXIMAL REGION DNA BINDING 118 371 3.065e-05 0.0003651
79 EPHRIN RECEPTOR BINDING 15 24 3.347e-05 0.0003936
80 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 12 17 3.585e-05 0.0004163
81 GATED CHANNEL ACTIVITY 105 325 4.039e-05 0.0004633
82 TRANSITION METAL ION BINDING 379 1400 4.24e-05 0.0004804
83 VIRUS RECEPTOR ACTIVITY 31 70 5.097e-05 0.0005704
84 I SMAD BINDING 9 11 5.578e-05 0.0006169
85 HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES 233 820 6.053e-05 0.0006615
86 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 13 20 6.32e-05 0.0006827
87 TRANSCRIPTION COACTIVATOR ACTIVITY 96 296 7.174e-05 0.0007661
88 ATP DEPENDENT MICROTUBULE MOTOR ACTIVITY 12 18 8.522e-05 0.0008895
89 MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING 12 18 8.522e-05 0.0008895
90 PHOSPHORIC ESTER HYDROLASE ACTIVITY 115 368 8.792e-05 0.0009075
91 R SMAD BINDING 14 23 9.34e-05 0.0009535
92 CATION CHANNEL ACTIVITY 96 298 9.508e-05 0.0009601
93 TRANSFORMING GROWTH FACTOR BETA BINDING 11 16 0.0001127 0.001102
94 LIGAND GATED CALCIUM CHANNEL ACTIVITY 11 16 0.0001127 0.001102
95 MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 11 16 0.0001127 0.001102
96 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 30 70 0.0001391 0.001346
97 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 59 168 0.000165 0.00158
98 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 36 90 0.0001744 0.001653
99 HISTONE KINASE ACTIVITY 12 19 0.0001834 0.001721
100 UBIQUITIN LIKE PROTEIN TRANSFERASE ACTIVITY 127 420 0.0001916 0.00178
101 LAMIN BINDING 11 17 0.0002535 0.002332
102 CYTOKINE BINDING 36 92 0.000291 0.002651
103 PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING 30 73 0.0003387 0.003055
104 GLYCOSAMINOGLYCAN BINDING 68 205 0.0003747 0.003284
105 FIBRONECTIN BINDING 15 28 0.0003737 0.003284
106 INTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY 15 28 0.0003737 0.003284
107 ACTIN FILAMENT BINDING 44 121 0.0004531 0.003934
108 TRANSCRIPTION COREPRESSOR ACTIVITY 72 221 0.0004643 0.003994
109 COLLAGEN BINDING 27 65 0.0005382 0.004587
110 RHO GTPASE BINDING 31 78 0.0005447 0.0046
111 TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS 88 282 0.0005839 0.004887
112 SEMAPHORIN RECEPTOR ACTIVITY 8 11 0.0005937 0.004924
113 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 10 16 0.0007337 0.006032
114 RAB GTPASE BINDING 43 120 0.0007429 0.006054
115 PROTEIN TYROSINE PHOSPHATASE ACTIVITY 38 103 0.0007808 0.006307
116 PROTEIN PHOSPHORYLATED AMINO ACID BINDING 13 24 0.0008016 0.00642
117 TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS 66 203 0.0008287 0.00658
118 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 45 128 0.0009019 0.006982
119 ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 90 293 0.0008911 0.006982
120 CHEMOREPELLENT ACTIVITY 14 27 0.0008996 0.006982
121 EXTRACELLULAR MATRIX BINDING 22 51 0.0009374 0.007197
122 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 21 48 0.0009741 0.007239
123 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 15 30 0.0009688 0.007239
124 PHOSPHOLIPID TRANSPORTER ACTIVITY 21 48 0.0009741 0.007239
125 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 38 104 0.0009644 0.007239
126 SCAFFOLD PROTEIN BINDING 20 45 0.001005 0.007405
127 PHOSPHATIDYLSERINE BINDING 16 33 0.001012 0.007405
128 MAP KINASE ACTIVITY 9 14 0.00103 0.007475
129 SIGNALING ADAPTOR ACTIVITY 29 74 0.001056 0.007552
130 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 37 101 0.001057 0.007552
131 SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 47 136 0.00107 0.00759
132 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 38 105 0.001185 0.00834
133 PROTEIN COMPLEX SCAFFOLD 27 68 0.001229 0.008584
134 CLATHRIN BINDING 26 65 0.001322 0.009166
135 BHLH TRANSCRIPTION FACTOR BINDING 14 28 0.001426 0.009528
136 CO SMAD BINDING 8 12 0.001425 0.009528
137 ACTIVIN BINDING 8 12 0.001425 0.009528
138 SULFURIC ESTER HYDROLASE ACTIVITY 10 17 0.00142 0.009528
139 HISTONE ACETYLTRANSFERASE BINDING 14 28 0.001426 0.009528
140 GLUTAMATE RECEPTOR BINDING 17 37 0.001512 0.009964
141 PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING 16 34 0.001512 0.009964
NumGOOverlapSizeP ValueAdj. P Value
1 CELL JUNCTION 440 1151 1.82e-34 1.063e-31
2 SYNAPSE 309 754 2.53e-30 7.387e-28
3 MEMBRANE REGION 418 1134 9.206e-29 1.792e-26
4 CELL PROJECTION 597 1786 1.088e-27 1.589e-25
5 NEURON PART 447 1265 3.628e-26 4.238e-24
6 NEURON PROJECTION 351 942 3.705e-25 3.606e-23
7 ANCHORING JUNCTION 211 489 2.585e-24 2.156e-22
8 SYNAPSE PART 247 610 1.594e-23 1.163e-21
9 CELL PROJECTION PART 342 946 5.828e-22 3.782e-20
10 GOLGI APPARATUS 480 1445 1.459e-21 8.52e-20
11 PLASMA MEMBRANE REGION 335 929 2.55e-21 1.354e-19
12 CELL SUBSTRATE JUNCTION 174 398 5.505e-21 2.679e-19
13 POSTSYNAPSE 166 378 2.551e-20 1.146e-18
14 EXCITATORY SYNAPSE 100 197 5.978e-18 2.494e-16
15 ENDOPLASMIC RETICULUM 511 1631 3.553e-17 1.383e-15
16 PERINUCLEAR REGION OF CYTOPLASM 235 642 4.232e-16 1.545e-14
17 MEMBRANE MICRODOMAIN 127 288 4.937e-16 1.696e-14
18 DENDRITE 178 451 5.466e-16 1.773e-14
19 EXTRACELLULAR MATRIX COMPONENT 70 125 7.659e-16 2.354e-14
20 GOLGI APPARATUS PART 304 893 1.85e-15 5.402e-14
21 SOMATODENDRITIC COMPARTMENT 234 650 4.243e-15 1.18e-13
22 AXON 165 418 6.341e-15 1.683e-13
23 CELL SURFACE 262 757 2.071e-14 5.258e-13
24 INTRINSIC COMPONENT OF PLASMA MEMBRANE 500 1649 5.2e-14 1.265e-12
25 CELL LEADING EDGE 140 350 2.179e-13 5.089e-12
26 BASEMENT MEMBRANE 53 93 9.378e-13 2.106e-11
27 PROTEINACEOUS EXTRACELLULAR MATRIX 139 356 2.256e-12 4.879e-11
28 VACUOLE 368 1180 2.916e-12 6.082e-11
29 INTRACELLULAR VESICLE 388 1259 4.36e-12 8.779e-11
30 ENDOPLASMIC RETICULUM PART 362 1163 5.885e-12 1.146e-10
31 GOLGI MEMBRANE 234 703 4.479e-11 8.439e-10
32 ENDOSOME 258 793 6.327e-11 1.155e-09
33 EXTRACELLULAR MATRIX 155 426 7.736e-11 1.369e-09
34 CELL CELL JUNCTION 142 383 1.065e-10 1.829e-09
35 PLASMA MEMBRANE PROTEIN COMPLEX 176 510 5.469e-10 9.125e-09
36 APICAL PART OF CELL 132 361 1.352e-09 2.155e-08
37 CELL BODY 170 494 1.365e-09 2.155e-08
38 CYTOPLASMIC REGION 110 287 1.525e-09 2.344e-08
39 ACTIN CYTOSKELETON 153 444 8.148e-09 1.182e-07
40 CYTOSKELETON 549 1967 8.301e-09 1.182e-07
41 MICROTUBULE ASSOCIATED COMPLEX 64 145 8.192e-09 1.182e-07
42 RECEPTOR COMPLEX 119 327 1.183e-08 1.645e-07
43 MEMBRANE PROTEIN COMPLEX 307 1020 1.297e-08 1.761e-07
44 NEURONAL POSTSYNAPTIC DENSITY 31 53 2.105e-08 2.794e-07
45 NEURON SPINE 55 121 2.597e-08 3.37e-07
46 NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK 301 1005 3.067e-08 3.894e-07
47 CELL CORTEX 91 238 4.376e-08 5.438e-07
48 AXON PART 85 219 5.508e-08 6.701e-07
49 FILOPODIUM 45 94 7.089e-08 8.448e-07
50 VESICLE MEMBRANE 168 512 7.482e-08 8.739e-07
51 T TUBULE 27 45 8.18e-08 9.367e-07
52 APICAL PLASMA MEMBRANE 106 292 8.422e-08 9.458e-07
53 PRESYNAPSE 103 283 1.1e-07 1.212e-06
54 SIDE OF MEMBRANE 144 428 1.187e-07 1.284e-06
55 SYNAPTIC MEMBRANE 96 261 1.661e-07 1.764e-06
56 BASOLATERAL PLASMA MEMBRANE 81 211 1.935e-07 2.017e-06
57 LAMELLIPODIUM 69 172 2.21e-07 2.264e-06
58 COMPLEX OF COLLAGEN TRIMERS 17 23 2.665e-07 2.683e-06
59 KINESIN COMPLEX 30 55 3.002e-07 2.971e-06
60 PLASMA MEMBRANE RAFT 41 86 3.072e-07 2.99e-06
61 CELL CELL CONTACT ZONE 33 64 4.473e-07 4.282e-06
62 SITE OF POLARIZED GROWTH 61 149 4.76e-07 4.483e-06
63 MICROTUBULE 135 405 5.259e-07 4.875e-06
64 CELL PROJECTION MEMBRANE 104 298 9.818e-07 8.959e-06
65 VACUOLAR PART 211 694 1.165e-06 1.047e-05
66 EARLY ENDOSOME 104 301 1.665e-06 1.474e-05
67 SARCOLEMMA 52 125 1.828e-06 1.594e-05
68 ACTIN BASED CELL PROJECTION 69 181 2.015e-06 1.731e-05
69 MYELIN SHEATH 65 168 2.183e-06 1.822e-05
70 MIDBODY 54 132 2.167e-06 1.822e-05
71 ACTOMYOSIN 31 62 2.338e-06 1.923e-05
72 INTERCALATED DISC 27 51 2.535e-06 2.057e-05
73 ORGANELLE SUBCOMPARTMENT 106 311 2.719e-06 2.175e-05
74 LEADING EDGE MEMBRANE 54 134 3.725e-06 2.94e-05
75 MICROTUBULE CYTOSKELETON 304 1068 4.019e-06 3.129e-05
76 CYTOPLASMIC VESICLE PART 183 601 5.319e-06 4.087e-05
77 VACUOLAR MEMBRANE 179 587 6.091e-06 4.62e-05
78 ENDOPLASMIC RETICULUM LUMEN 73 201 8.002e-06 5.991e-05
79 POSTSYNAPTIC MEMBRANE 74 205 8.931e-06 6.602e-05
80 NUCLEAR ENVELOPE 132 416 1.22e-05 8.908e-05
81 CATION CHANNEL COMPLEX 62 167 1.713e-05 0.0001235
82 TRANSPORT VESICLE 110 338 1.889e-05 0.0001346
83 PLASMA MEMBRANE RECEPTOR COMPLEX 64 175 2.189e-05 0.0001505
84 LATERAL PLASMA MEMBRANE 25 50 2.19e-05 0.0001505
85 EXTRINSIC COMPONENT OF MEMBRANE 86 252 2.151e-05 0.0001505
86 APICAL JUNCTION COMPLEX 50 128 2.291e-05 0.0001538
87 TRANSPORTER COMPLEX 105 321 2.278e-05 0.0001538
88 RUFFLE 58 156 2.999e-05 0.000199
89 PIGMENT GRANULE 42 103 3.068e-05 0.0002013
90 CYTOPLASMIC SIDE OF MEMBRANE 62 170 3.212e-05 0.0002084
91 ACTIN FILAMENT BUNDLE 27 57 3.608e-05 0.0002315
92 TRANS GOLGI NETWORK 68 193 4.899e-05 0.000311
93 NUCLEAR MEMBRANE 92 280 5.874e-05 0.0003689
94 RUFFLE MEMBRANE 34 80 6.313e-05 0.0003922
95 CELL CORTEX PART 46 119 6.455e-05 0.0003968
96 OUTER MEMBRANE 66 190 0.000102 0.0006203
97 LYTIC VACUOLE 156 526 0.0001108 0.0006672
98 POTASSIUM CHANNEL COMPLEX 36 90 0.0001744 0.00103
99 CONTRACTILE FIBER 71 211 0.0001746 0.00103
100 CYTOSKELETAL PART 382 1436 0.0001858 0.001085
101 SARCOPLASM 29 68 0.000198 0.001145
102 COATED VESICLE 77 234 0.0002133 0.001221
103 EXOCYTIC VESICLE 51 142 0.0002381 0.00135
104 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 16 30 0.0002556 0.001435
105 NEURON PROJECTION TERMINUS 47 129 0.0002809 0.001562
106 CELL CELL ADHERENS JUNCTION 24 54 0.0003266 0.001782
107 NEUROMUSCULAR JUNCTION 24 54 0.0003266 0.001782
108 BASAL PART OF CELL 23 51 0.0003332 0.001802
109 FILAMENTOUS ACTIN 12 20 0.0003637 0.001948
110 ENDOSOMAL PART 128 430 0.0003707 0.001968
111 EXTERNAL SIDE OF PLASMA MEMBRANE 77 238 0.0003829 0.002014
112 MAIN AXON 25 58 0.0004388 0.002288
113 DENDRITIC SHAFT 18 37 0.0004719 0.002439
114 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 48 136 0.000562 0.002879
115 SEMAPHORIN RECEPTOR COMPLEX 8 11 0.0005937 0.003015
116 EXOCYTIC VESICLE MEMBRANE 24 56 0.0006274 0.003158
117 ANCHORED COMPONENT OF MEMBRANE 52 152 0.0007848 0.003917
118 SECRETORY VESICLE 134 461 0.0007991 0.003955
119 ACTIN FILAMENT 28 70 0.0008787 0.004312
120 COATED PIT 27 67 0.0009425 0.004587
121 COSTAMERE 11 19 0.0009782 0.004721
122 CLATHRIN COATED VESICLE 53 157 0.0009967 0.004771
123 BASAL PLASMA MEMBRANE 16 33 0.001012 0.004806
124 VOLTAGE GATED SODIUM CHANNEL COMPLEX 9 14 0.00103 0.00485
125 BRUSH BORDER 37 102 0.0013 0.006076
126 SODIUM CHANNEL COMPLEX 10 17 0.00142 0.006503
127 PARANODE REGION OF AXON 8 12 0.001425 0.006503
128 BANDED COLLAGEN FIBRIL 8 12 0.001425 0.006503
129 EARLY ENDOSOME MEMBRANE 40 113 0.001455 0.006586
130 ENDOCYTIC VESICLE 79 256 0.001531 0.006878
131 RECYCLING ENDOSOME 45 131 0.00155 0.00691
132 TRANSCRIPTION FACTOR COMPLEX 90 298 0.001581 0.006996
133 PROTEIN KINASE COMPLEX 33 90 0.001883 0.008268
134 PML BODY 35 97 0.001922 0.008377

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04510_Focal_adhesion 102 200 1.815e-18 3.267e-16
2 hsa04151_PI3K_AKT_signaling_pathway 141 351 1.209e-13 1.088e-11
3 hsa04512_ECM.receptor_interaction 47 85 7.574e-11 4.545e-09
4 hsa04144_Endocytosis 86 203 3.131e-10 1.409e-08
5 hsa04520_Adherens_junction 41 73 6.391e-10 2.301e-08
6 hsa04390_Hippo_signaling_pathway 68 154 2.778e-09 7.449e-08
7 hsa04810_Regulation_of_actin_cytoskeleton 87 214 2.897e-09 7.449e-08
8 hsa04310_Wnt_signaling_pathway 66 151 7.789e-09 1.753e-07
9 hsa04012_ErbB_signaling_pathway 44 87 1.226e-08 2.452e-07
10 hsa04014_Ras_signaling_pathway 90 236 5.966e-08 1.074e-06
11 hsa04360_Axon_guidance 57 130 6.969e-08 1.14e-06
12 hsa04722_Neurotrophin_signaling_pathway 54 127 5.101e-07 7.651e-06
13 hsa04916_Melanogenesis 45 101 9.326e-07 1.291e-05
14 hsa04010_MAPK_signaling_pathway 95 268 1.31e-06 1.684e-05
15 hsa04380_Osteoclast_differentiation 53 128 1.733e-06 2.08e-05
16 hsa04912_GnRH_signaling_pathway 44 101 2.575e-06 2.896e-05
17 hsa04910_Insulin_signaling_pathway 55 138 4.53e-06 4.796e-05
18 hsa04540_Gap_junction 39 90 1.09e-05 0.000109
19 hsa04720_Long.term_potentiation 32 70 1.768e-05 0.0001675
20 hsa04971_Gastric_acid_secretion 33 74 2.481e-05 0.0002233
21 hsa04350_TGF.beta_signaling_pathway 36 85 4.255e-05 0.0003647
22 hsa04020_Calcium_signaling_pathway 63 177 6.464e-05 0.0005233
23 hsa04514_Cell_adhesion_molecules_.CAMs. 51 136 6.795e-05 0.0005233
24 hsa04270_Vascular_smooth_muscle_contraction 45 116 6.977e-05 0.0005233
25 hsa04115_p53_signaling_pathway 30 69 0.0001013 0.0007296
26 hsa04150_mTOR_signaling_pathway 24 52 0.0001606 0.001112
27 hsa04974_Protein_digestion_and_absorption 33 81 0.0002128 0.001419
28 hsa04070_Phosphatidylinositol_signaling_system 32 78 0.0002264 0.001455
29 hsa04730_Long.term_depression 29 70 0.0003594 0.002231
30 hsa04972_Pancreatic_secretion 38 101 0.0005033 0.00302
31 hsa04970_Salivary_secretion 34 89 0.0007059 0.004099
32 hsa04914_Progesterone.mediated_oocyte_maturation 33 87 0.0009694 0.005453
33 hsa04666_Fc_gamma_R.mediated_phagocytosis 35 95 0.001268 0.006915
34 hsa04960_Aldosterone.regulated_sodium_reabsorption 18 42 0.002901 0.01536
35 hsa04141_Protein_processing_in_endoplasmic_reticulum 54 168 0.003069 0.01578
36 hsa00510_N.Glycan_biosynthesis 20 49 0.003474 0.01737
37 hsa04320_Dorso.ventral_axis_formation 12 25 0.004752 0.02312
38 hsa04210_Apoptosis 31 89 0.006151 0.02914
39 hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series 12 26 0.007024 0.03242
40 hsa00533_Glycosaminoglycan_biosynthesis_._keratan_sulfate 8 15 0.009551 0.04249
41 hsa04670_Leukocyte_transendothelial_migration 38 117 0.009679 0.04249
42 hsa04630_Jak.STAT_signaling_pathway 48 155 0.01075 0.04608
43 hsa00562_Inositol_phosphate_metabolism 21 57 0.01105 0.04627
44 hsa04530_Tight_junction 42 133 0.01147 0.04691
45 hsa04962_Vasopressin.regulated_water_reabsorption 17 44 0.01269 0.05071
46 hsa04660_T_cell_receptor_signaling_pathway 35 108 0.01311 0.05071
47 hsa04664_Fc_epsilon_RI_signaling_pathway 27 79 0.01324 0.05071
48 hsa04114_Oocyte_meiosis 36 114 0.0182 0.06825
49 hsa04340_Hedgehog_signaling_pathway 20 56 0.01862 0.06839
50 hsa04710_Circadian_rhythm_._mammal 10 23 0.02168 0.07806
51 hsa04920_Adipocytokine_signaling_pathway 23 68 0.02392 0.08441
52 hsa00512_Mucin_type_O.Glycan_biosynthesis 12 30 0.0254 0.08792
53 hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism 17 48 0.03111 0.1056
54 hsa04662_B_cell_receptor_signaling_pathway 24 75 0.0409 0.1363
55 hsa04145_Phagosome 45 156 0.04374 0.1432
56 hsa04370_VEGF_signaling_pathway 24 76 0.0473 0.152
57 hsa02010_ABC_transporters 15 44 0.05689 0.1796
58 hsa04976_Bile_secretion 22 71 0.06724 0.2087
59 hsa04640_Hematopoietic_cell_lineage 26 88 0.0828 0.2526
60 hsa00480_Glutathione_metabolism 16 50 0.08428 0.2528
61 hsa00250_Alanine._aspartate_and_glutamate_metabolism 11 32 0.09014 0.266
62 hsa04062_Chemokine_signaling_pathway 51 189 0.09509 0.2753
63 hsa04130_SNARE_interactions_in_vesicular_transport 12 36 0.09636 0.2753
64 hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series 6 15 0.1027 0.2848
65 hsa00410_beta.Alanine_metabolism 8 22 0.1048 0.2848
66 hsa04620_Toll.like_receptor_signaling_pathway 29 102 0.1052 0.2848
67 hsa04973_Carbohydrate_digestion_and_absorption 14 44 0.106 0.2848
68 hsa00910_Nitrogen_metabolism 8 23 0.1302 0.3395
69 hsa03060_Protein_export 8 23 0.1302 0.3395
70 hsa00750_Vitamin_B6_metabolism 3 6 0.135 0.3471
71 hsa04142_Lysosome 33 121 0.1382 0.3479
72 hsa00052_Galactose_metabolism 9 27 0.1392 0.3479
73 hsa00260_Glycine._serine_and_threonine_metabolism 10 32 0.1716 0.4231
74 hsa00600_Sphingolipid_metabolism 12 40 0.1791 0.4358
75 hsa00564_Glycerophospholipid_metabolism 22 80 0.1853 0.4448
76 hsa00563_Glycosylphosphatidylinositol.GPI..anchor_biosynthesis 8 25 0.189 0.4477
77 hsa00603_Glycosphingolipid_biosynthesis_._globo_series 5 14 0.1947 0.4495
78 hsa00340_Histidine_metabolism 9 29 0.1948 0.4495
79 hsa00670_One_carbon_pool_by_folate 6 18 0.2079 0.4737
80 hsa04120_Ubiquitin_mediated_proteolysis 36 139 0.2106 0.4739
81 hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate 7 22 0.2164 0.4808
82 hsa00534_Glycosaminoglycan_biosynthesis_._heparan_sulfate 8 26 0.222 0.4873
83 hsa00561_Glycerolipid_metabolism 14 50 0.2301 0.499
84 hsa00531_Glycosaminoglycan_degradation 6 19 0.2492 0.5152
85 hsa04621_NOD.like_receptor_signaling_pathway 16 59 0.2518 0.5152
86 hsa03430_Mismatch_repair 7 23 0.2541 0.5152
87 hsa04964_Proximal_tubule_bicarbonate_reclamation 7 23 0.2541 0.5152
88 hsa04330_Notch_signaling_pathway 13 47 0.2565 0.5152
89 hsa00030_Pentose_phosphate_pathway 8 27 0.2569 0.5152
90 hsa00071_Fatty_acid_metabolism 12 43 0.2576 0.5152
91 hsa00280_Valine._leucine_and_isoleucine_degradation 12 44 0.2861 0.5392
92 hsa00770_Pantothenate_and_CoA_biosynthesis 5 16 0.2893 0.5392
93 hsa00051_Fructose_and_mannose_metabolism 10 36 0.2904 0.5392
94 hsa00565_Ether_lipid_metabolism 10 36 0.2904 0.5392
95 hsa04650_Natural_killer_cell_mediated_cytotoxicity 34 136 0.2917 0.5392
96 hsa00640_Propanoate_metabolism 9 32 0.2921 0.5392
97 hsa00760_Nicotinate_and_nicotinamide_metabolism 7 24 0.2936 0.5392
98 hsa04977_Vitamin_digestion_and_absorption 7 24 0.2936 0.5392
99 hsa00010_Glycolysis_._Gluconeogenesis 17 65 0.2967 0.5395
100 hsa00230_Purine_metabolism 39 162 0.3687 0.6636
101 hsa04110_Cell_cycle 31 128 0.375 0.6683
102 hsa00430_Taurine_and_hypotaurine_metabolism 3 10 0.405 0.7046
103 hsa04122_Sulfur_relay_system 3 10 0.405 0.7046
104 hsa04612_Antigen_processing_and_presentation 19 78 0.4071 0.7046
105 hsa03030_DNA_replication 9 36 0.4348 0.7454
106 hsa03440_Homologous_recombination 7 28 0.4584 0.7784
107 hsa04260_Cardiac_muscle_contraction 18 77 0.4891 0.8228
108 hsa00460_Cyanoamino_acid_metabolism 2 7 0.4965 0.8275
109 hsa04610_Complement_and_coagulation_cascades 16 69 0.5094 0.8412
110 hsa03015_mRNA_surveillance_pathway 19 83 0.5275 0.8604
111 hsa03010_Ribosome 21 92 0.5306 0.8604
112 hsa00310_Lysine_degradation 10 44 0.5579 0.8716
113 hsa00360_Phenylalanine_metabolism 4 17 0.5617 0.8716
114 hsa00450_Selenocompound_metabolism 4 17 0.5617 0.8716
115 hsa00511_Other_glycan_degradation 4 17 0.5617 0.8716
116 hsa03013_RNA_transport 34 152 0.5724 0.8807
117 hsa00330_Arginine_and_proline_metabolism 12 54 0.5873 0.8884
118 hsa00500_Starch_and_sucrose_metabolism 12 54 0.5873 0.8884
119 hsa00270_Cysteine_and_methionine_metabolism 8 36 0.5928 0.8891
120 hsa00350_Tyrosine_metabolism 9 41 0.6069 0.9013
121 hsa00630_Glyoxylate_and_dicarboxylate_metabolism 4 18 0.6109 0.9013
122 hsa03022_Basal_transcription_factors 8 37 0.6264 0.9117
123 hsa00380_Tryptophan_metabolism 9 42 0.6381 0.9117
124 hsa00072_Synthesis_and_degradation_of_ketone_bodies 2 9 0.6415 0.9117
125 hsa04622_RIG.I.like_receptor_signaling_pathway 15 71 0.6703 0.9427
126 hsa00240_Pyrimidine_metabolism 21 99 0.6775 0.9432
127 hsa04140_Regulation_of_autophagy 7 34 0.6812 0.9432
128 hsa00591_Linoleic_acid_metabolism 6 30 0.7069 0.9713
129 hsa00982_Drug_metabolism_._cytochrome_P450 15 73 0.714 0.973
130 hsa03420_Nucleotide_excision_repair 9 45 0.723 0.973
131 hsa00053_Ascorbate_and_aldarate_metabolism 5 26 0.7362 0.98
132 hsa00514_Other_types_of_O.glycan_biosynthesis 9 46 0.7481 0.98
133 hsa00740_Riboflavin_metabolism 2 11 0.7514 0.98
134 hsa00790_Folate_biosynthesis 2 11 0.7514 0.98
135 hsa03018_RNA_degradation 14 71 0.7684 0.9951
136 hsa04614_Renin.angiotensin_system 3 17 0.7779 1
137 hsa04672_Intestinal_immune_network_for_IgA_production 9 49 0.8138 1
138 hsa00590_Arachidonic_acid_metabolism 11 59 0.8154 1
139 hsa03050_Proteasome 8 45 0.8336 1
140 hsa00100_Steroid_biosynthesis 3 19 0.8404 1
141 hsa00020_Citrate_cycle_.TCA_cycle. 5 30 0.8442 1
142 hsa00650_Butanoate_metabolism 5 30 0.8442 1
143 hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 13 71 0.849 1
144 hsa03450_Non.homologous_end.joining 2 14 0.8614 1
145 hsa00592_alpha.Linolenic_acid_metabolism 3 20 0.8655 1
146 hsa04146_Peroxisome 14 79 0.8866 1
147 hsa00860_Porphyrin_and_chlorophyll_metabolism 7 43 0.8867 1
148 hsa01040_Biosynthesis_of_unsaturated_fatty_acids 3 21 0.8871 1
149 hsa04966_Collecting_duct_acid_secretion 4 27 0.8921 1
150 hsa03320_PPAR_signaling_pathway 12 70 0.8991 1
151 hsa00620_Pyruvate_metabolism 6 40 0.9182 1
152 hsa04975_Fat_digestion_and_absorption 7 46 0.9237 1
153 hsa00983_Drug_metabolism_._other_enzymes 8 52 0.9291 1
154 hsa00830_Retinol_metabolism 10 64 0.9393 1
155 hsa00040_Pentose_and_glucuronate_interconversions 4 32 0.9531 1
156 hsa03410_Base_excision_repair 4 34 0.967 1
157 hsa04742_Taste_transduction 7 52 0.9675 1
158 hsa03008_Ribosome_biogenesis_in_eukaryotes 12 81 0.9716 1
159 hsa04623_Cytosolic_DNA.sensing_pathway 7 56 0.9823 1
160 hsa03020_RNA_polymerase 2 29 0.9946 1
161 hsa00190_Oxidative_phosphorylation 18 132 0.9969 1
162 hsa00140_Steroid_hormone_biosynthesis 4 57 0.9996 1
163 hsa00970_Aminoacyl.tRNA_biosynthesis 4 63 0.9999 1
164 hsa03040_Spliceosome 13 128 0.9999 1
165 hsa04740_Olfactory_transduction 7 388 1 1

Quest ID: 75d9c6df3d9948c20b136b1cd7d7f5f0